SLP-76	B-protein
and	O
Vav	B-protein
function	O
in	O
separate	O
,	O
but	O
overlapping	O
pathways	O
to	O
augment	O
interleukin-2	B-DNA
promoter	I-DNA
activity	O
.	O

SLP-76	B-protein
and	O
Vav	B-protein
,	O
two	O
hematopoietic	B-protein
cell	I-protein
specific	I-protein
molecules	I-protein
,	O
are	O
critical	O
for	O
T	O
cell	O
development	O
and	O
activation	O
.	O

Following	O
T	B-protein
cell	I-protein
antigen	I-protein
receptor	I-protein
stimulation	O
,	O
SLP-76	B-protein
and	O
Vav	B-protein
both	O
undergo	O
tyrosine	O
phosphorylation	O
and	O
associate	O
with	O
each	O
other	O
via	O
the	O
SH2	O
domain	O
of	O
Vav	B-protein
and	O
phosphorylated	O
tyrosines	O
of	O
SLP-76	B-protein
.	O

Furthermore	O
,	O
SLP-76	B-protein
and	O
Vav	B-protein
have	O
a	O
synergistic	O
effect	O
on	O
interleukin	B-DNA
(	I-DNA
IL	I-DNA
)	I-DNA
-2	I-DNA
promoter	I-DNA
activity	O
in	O
T	B-cell_line
cells	I-cell_line
.	O

In	O
this	O
report	O
,	O
we	O
show	O
that	O
two	O
tyrosines	O
,	O
Tyr-113	O
and	O
Tyr-128	O
,	O
of	O
SLP-76	B-protein
are	O
required	O
for	O
its	O
binding	O
to	O
Vav	B-protein
,	O
both	O
in	O
vitro	O
and	O
in	O
intact	B-cell_type
cells	I-cell_type
.	O

Surprisingly	O
,	O
we	O
find	O
also	O
that	O
the	O
interaction	O
between	O
SLP-76	B-protein
and	O
Vav	B-protein
is	O
not	O
required	O
for	O
their	O
cooperation	O
in	O
augmenting	O
IL-2	B-DNA
promoter	I-DNA
activity	O
,	O
as	O
the	O
two	O
molecules	O
appear	O
to	O
function	O
in	O
different	O
signaling	O
pathways	O
upstream	O
of	O
IL-2	B-DNA
gene	I-DNA
expression	O
.	O

Overexpression	O
of	O
SLP-76	B-protein
in	O
the	O
Jurkat	B-cell_line
T	I-cell_line
cell	I-cell_line
line	I-cell_line
potentiates	O
the	O
activities	O
of	O
both	O
nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cells	I-protein
and	O
AP-1	B-protein
transcription	I-protein
factors	I-protein
.	O

In	O
contrast	O
,	O
overexpression	O
of	O
Vav	B-protein
leads	O
to	O
enhanced	O
nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cells	I-protein
activity	O
without	O
affecting	O
AP-1	B-protein
.	O

Additionally	O
,	O
overexpression	O
of	O
Vav	B-protein
,	O
but	O
not	O
SLP-76	B-protein
,	O
augments	O
CD28-induced	O
IL-2	B-DNA
promoter	I-DNA
activity	O
.	O

These	O
findings	O
suggest	O
that	O
the	O
synergy	O
between	O
SLP-76	B-protein
and	O
Vav	B-protein
in	O
regulating	O
IL-2	B-DNA
gene	I-DNA
expression	O
reflects	O
the	O
cooperation	O
between	O
different	O
signaling	O
pathways	O
.	O

THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

274	NULL
,	NULL
No	NULL
.	NULL

23	NULL
,	NULL
Issue	NULL
of	NULL
June	NULL
4	NULL
,	NULL
pp	NULL
.	NULL

16206-16212	NULL
,	NULL
1999	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
SLP-76	NULL
and	NULL
Vav	NULL
Function	NULL
in	NULL
Separate	NULL
,	NULL
but	NULL
Overlapping	NULL
Pathways	NULL
to	NULL
Augment	NULL
Interleukin-2	NULL
Promoter	NULL
Activity*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
February	NULL
12	NULL
,	NULL
1999	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
March	NULL
27	NULL
,	NULL
1999	NULL
)	NULL
Nan	NULL
Fangt	NULL
#	NULL
and	NULL
Gary	NULL
A.	NULL
Koretzky	NULL
$	NULL
§1	NULL
From	NULL
the	NULL
{	NULL
Graduate	NULL
Program	NULL
in	NULL
Immunology	NULL
and	NULL
the	NULL
§Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Iowa	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
Iowa	NULL
City	NULL
,	NULL
Iowa	NULL
52242	NULL
SLP-76	NULL
and	NULL
Vav	NULL
,	NULL
two	NULL
hematopoietic	NULL
cell	NULL
specific	NULL
molecules	NULL
,	NULL
are	NULL
critical	NULL
for	NULL
T	NULL
cell	NULL
development	NULL
and	NULL
activation	NULL
.	NULL

Following	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
stimulation	NULL
,	NULL
SLP-76	NULL
and	NULL
Vav	NULL
both	NULL
undergo	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
associate	NULL
with	NULL
each	NULL
other	NULL
via	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
Vav	NULL
and	NULL
phosphorylated	NULL
tyrosines	NULL
of	NULL
SLP-76	NULL
.	NULL

Furthermore	NULL
,	NULL
SLP-76	NULL
and	NULL
Vav	NULL
have	NULL
a	NULL
synergistic	NULL
effect	NULL
on	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-2	NULL
promoter	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
show	NULL
that	NULL
two	NULL
tyrosines	NULL
,	NULL
Tyr-113	NULL
and	NULL
Tyr-128	NULL
,	NULL
of	NULL
SLP-76	NULL
are	NULL
required	NULL
for	NULL
its	NULL
binding	NULL
to	NULL
Vav	NULL
,	NULL
both	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
intact	NULL
cells	NULL
.	NULL

Surprisingly	NULL
,	NULL
we	NULL
find	NULL
also	NULL
that	NULL
the	NULL
interaction	NULL
between	NULL
SLP-76	NULL
and	NULL
Vav	NULL
is	NULL
not	NULL
required	NULL
for	NULL
their	NULL
cooperation	NULL
in	NULL
augmenting	NULL
IL-2	NULL
promoter	NULL
activity	NULL
,	NULL
as	NULL
the	NULL
two	NULL
molecules	NULL
appear	NULL
to	NULL
function	NULL
in	NULL
different	NULL
signaling	NULL
pathways	NULL
upstream	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
.	NULL

Overexpression	NULL
of	NULL
SLP-76	NULL
in	NULL
the	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
potentiates	NULL
the	NULL
activities	NULL
of	NULL
both	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
and	NULL
AP-1	NULL
transcription	NULL
factors	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
overexpression	NULL
of	NULL
Vav	NULL
leads	NULL
to	NULL
enhanced	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
activity	NULL
without	NULL
affecting	NULL
AP-1	NULL
.	NULL

Additionally	NULL
,	NULL
overexpression	NULL
of	NULL
Vav	NULL
,	NULL
but	NULL
not	NULL
SLP-76	NULL
,	NULL
augments	NULL
CD28-induced	NULL
IL-2	NULL
promoter	NULL
activity	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
the	NULL
synergy	NULL
between	NULL
SLP-76	NULL
and	NULL
Vav	NULL
in	NULL
regulating	NULL
IL-2	NULL
gene	NULL
expression	NULL
reflects	NULL
the	NULL
cooperation	NULL
between	NULL
different	NULL
signaling	NULL
pathways	NULL
.	NULL

Recognition	NULL
of	NULL
specific	NULL
antigen	NULL
by	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
initiates	NULL
biochemical	NULL
changes	NULL
including	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
calcium	NULL
influx	NULL
,	NULL
metabolism	NULL
of	NULL
phospho-lipids	NULL
,	NULL
and	NULL
activation	NULL
of	NULL
the	NULL
Ras/MAPK	NULL
cascade	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Together	NULL
with	NULL
signaling	NULL
events	NULL
initiated	NULL
by	NULL
engagement	NULL
of	NULL
co-receptors	NULL
on	NULL
the	NULL
T	NULL
cell	NULL
,	NULL
these	NULL
biological	NULL
second	NULL
messengers	NULL
lead	NULL
to	NULL
cytokine	NULL
production	NULL
,	NULL
proliferation	NULL
,	NULL
and	NULL
differentiation	NULL
,	NULL
or	NULL
conversely	NULL
programmed	NULL
cell	NULL
death	NULL
(	NULL
3-5	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
(	NULL
PTKs	NULL
)	NULL
of	NULL
the	NULL
Sre	NULL
and	NULL
Syk	NULL
families	NULL
is	NULL
the	NULL
most	NULL
membrane-proximal	NULL
biochemical	NULL
event	NULL
known	NULL
following	NULL
TCR	NULL
engagement	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Phosphorylation	NULL
of	NULL
cellular	NULL
proteins	NULL
by	NULL
these	NULL
kinases	NULL
is	NULL
essential	NULL
for	NULL
all	NULL
subsequent	NULL
TCR-initiated	NULL
signaling	NULL
pathways	NULL
.	NULL

PTK	NULL
activation	NULL
may	NULL
result	NULL
in	NULL
downstream	NULL
signals	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
ROIGM53256	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
17834	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

«	NULL
Established	NULL
Investigator	NULL
of	NULL
the	NULL
American	NULL
Heart	NULL
Association	NULL
.	NULL

To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
540	NULL
EMRB	NULL
,	NULL
Dept	NULL
.	NULL

of	NULL
Internal	NULL
Medicine	NULL
,	NULL
Univ	NULL
.	NULL

of	NULL
Iowa	NULL
,	NULL
Iowa	NULL
City	NULL
,	NULL
IA	NULL
52242	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
819-835-6844	NULL
;	NULL
Fax	NULL
:	NULL
319-385-6887	NULL
;	NULL
E-mail	NULL
:	NULL
gary-koretzky	NULL
@	NULL
uiowa.edu	NULL
.	NULL

*The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
TCR	NULL
,	NULL
T	NULL
cell	NULL
receptor	NULL
;	NULL
PTK	NULL
,	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
;	NULL
SH2	NULL
,	NULL
Sre	NULL
homology	NULL
domain	NULL
2	NULL
;	NULL
IL-2	NULL
,	NULL
interleukin-2	NULL
;	NULL
NFAT	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
;	NULL
mAb	NULL
,	NULL
monoclonal	NULL
antibody	NULL
;	NULL
B-Gal	NULL
,	NULL
B-galactosidase	NULL
;	NULL
GST	NULL
,	NULL
glutathione	NULL
S-transferase	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
;	NULL
PAGE	NULL
,	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
;	NULL
MBP	NULL
,	NULL
myelin	NULL
basic	NULL
protein	NULL
;	NULL
ERK	NULL
,	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
.	NULL

16206	NULL
through	NULL
direct	NULL
phosphorylation	NULL
and	NULL
modulation	NULL
of	NULL
the	NULL
catalytic	NULL
activities	NULL
of	NULL
effector	NULL
molecules	NULL
(	NULL
such	NULL
as	NULL
phospholipase	NULL
C-y1	NULL
)	NULL
or	NULL
the	NULL
formation	NULL
of	NULL
signaling	NULL
complexes	NULL
by	NULL
the	NULL
interaction	NULL
of	NULL
proteins	NULL
newly	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
residues	NULL
with	NULL
other	NULL
Src	NULL
homology	NULL
2	NULL
(	NULL
SH2	NULL
)	NULL
or	NULL
phosphotyrosine-binding	NULL
domain-contain-ing	NULL
proteins	NULL
within	NULL
the	NULL
cell	NULL
.	NULL

A	NULL
widely	NULL
studied	NULL
example	NULL
of	NULL
this	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
the	NULL
recruitment	NULL
of	NULL
ZAP-70	NULL
to	NULL
the	NULL
newly	NULL
phosphorylated	NULL
tyrosines	NULL
of	NULL
immune	NULL
receptor	NULL
activation	NULL
motifs	NULL
(	NULL
ITAMs	NULL
)	NULL
on	NULL
the	NULL
TCR	NULL
{	NULL
and	NULL
CD3	NULL
chains	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

Given	NULL
the	NULL
central	NULL
importance	NULL
of	NULL
PTKs	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
a	NULL
number	NULL
of	NULL
laboratories	NULL
have	NULL
attempted	NULL
to	NULL
identify	NULL
substrates	NULL
of	NULL
these	NULL
PTKs	NULL
in	NULL
an	NULL
effort	NULL
to	NULL
gain	NULL
insight	NULL
into	NULL
how	NULL
biochemical	NULL
signals	NULL
are	NULL
integrated	NULL
.	NULL

Among	NULL
the	NULL
substrates	NULL
identified	NULL
are	NULL
the	NULL
hematopoietic	NULL
cell-specific	NULL
molecules	NULL
SH2	NULL
domain	NULL
containing	NULL
leukocyte	NULL
phosphoprotein	NULL
of	NULL
76	NULL
kDa	NULL
(	NULL
SLP-76	NULL
)	NULL
and	NULL
Vav	NULL
,	NULL
both	NULL
of	NULL
which	NULL
play	NULL
critical	NULL
roles	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
TCR	NULL
signals	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

SLP-76	NULL
is	NULL
an	NULL
adapter	NULL
protein	NULL
which	NULL
is	NULL
comprised	NULL
of	NULL
three	NULL
motifs	NULL
allowing	NULL
for	NULL
protein-protein	NULL
interactions	NULL
:	NULL
an	NULL
amino-terminal	NULL
acidic	NULL
region	NULL
containing	NULL
tyrosine	NULL
phosphorylation	NULL
sites	NULL
(	NULL
11	NULL
)	NULL
,	NULL
a	NULL
middle	NULL
proline-rich	NULL
motif	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
SH3	NULL
domain	NULL
of	NULL
Grb2	NULL
family	NULL
members	NULL
(	NULL
9	NULL
,	NULL
12	NULL
)	NULL
,	NULL
and	NULL
a	NULL
carboxyl-terminal	NULL
SH2	NULL
domain	NULL
that	NULL
associates	NULL
with	NULL
SLP-76-associated	NULL
phosphoprotein	NULL
of	NULL
130	NULL
kDa	NULL
(	NULL
SLAP-130	NULL
or	NULL
FYB	NULL
,	NULL
for	NULL
Fyn-binding	NULL
protein	NULL
)	NULL
and	NULL
another	NULL
unidentified	NULL
62-kDa	NULL
phosphoprotein	NULL
(	NULL
13-15	NULL
)	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
SLP-76	NULL
in	NULL
T	NULL
cell	NULL
signaling	NULL
has	NULL
been	NULL
demonstrated	NULL
in	NULL
experiments	NULL
in	NULL
the	NULL
Jurkat	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
line	NULL
and	NULL
in	NULL
mice	NULL
made	NULL
deficient	NULL
in	NULL
SLP-76	NULL
expression	NULL
through	NULL
homologous	NULL
re-combination	NULL
.	NULL

When	NULL
SLP-76	NULL
is	NULL
overexpressed	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
there	NULL
is	NULL
a	NULL
dramatic	NULL
augmentation	NULL
of	NULL
TCR-mediated	NULL
activation	NULL
of	NULL
the	NULL
full-length	NULL
IL-2	NULL
promoter	NULL
or	NULL
a	NULL
reporter	NULL
construct	NULL
driven	NULL
by	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
element	NULL
from	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
9	NULL
,	NULL
16	NULL
)	NULL
.	NULL

Each	NULL
of	NULL
the	NULL
three	NULL
structural	NULL
domains	NULL
of	NULL
SLP-76	NULL
are	NULL
essential	NULL
for	NULL
this	NULL
enhanced	NULL
promoter	NULL
activity	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
TCR-mediated	NULL
signals	NULL
are	NULL
abrogated	NULL
in	NULL
a	NULL
mutant	NULL
variant	NULL
of	NULL
Jurkat	NULL
which	NULL
has	NULL
lost	NULL
expression	NULL
of	NULL
SLP-76	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Studies	NULL
of	NULL
SLP-76-deficient	NULL
mice	NULL
indicate	NULL
also	NULL
that	NULL
this	NULL
adapter	NULL
protein	NULL
is	NULL
critical	NULL
for	NULL
signaling	NULL
via	NULL
the	NULL
pre-TCR	NULL
,	NULL
as	NULL
these	NULL
mice	NULL
exhibit	NULL
arrest	NULL
of	NULL
thymocyte	NULL
development	NULL
at	NULL
the	NULL
pro-T3	NULL
,	NULL
CD3~	NULL
CD4~	NULL
CD8~	NULL
stage	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

Vav	NULL
is	NULL
a	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
factor	NULL
which	NULL
acts	NULL
on	NULL
members	NULL
of	NULL
the	NULL
Rac/Rho	NULL
family	NULL
of	NULL
small	NULL
GTP-binding	NULL
proteins	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

Vav	NULL
has	NULL
a	NULL
pleckstrin	NULL
homology	NULL
,	NULL
a	NULL
Dbl	NULL
homology	NULL
,	NULL
an	NULL
SH2	NULL
,	NULL
and	NULL
two	NULL
Sre	NULL
homology	NULL
3	NULL
(	NULL
SH3	NULL
)	NULL
domains	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

The	NULL
Dbl	NULL
homology	NULL
domain	NULL
of	NULL
Vav	NULL
is	NULL
responsible	NULL
for	NULL
its	NULL
nucleotide	NULL
exchange	NULL
activity	NULL
while	NULL
the	NULL
pleckstrin	NULL
homology	NULL
domain	NULL
regulates	NULL
interactions	NULL
with	NULL
inositol	NULL
phospholipids	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
SH2	NULL
and	NULL
SH3	NULL
domains	NULL
mediate	NULL
the	NULL
interaction	NULL
of	NULL
Vav	NULL
with	NULL
other	NULL
signaling	NULL
molecules	NULL
,	NULL
including	NULL
SLP-76	NULL
(	NULL
26-29	NULL
)	NULL
.	NULL

Like	NULL
SLP-76	NULL
,	NULL
Vav	NULL
is	NULL
critical	NULL
for	NULL
effective	NULL
TCR	NULL
signaling	NULL
.	NULL

Its	NULL
overexpression	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
also	NULL
augments	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
following	NULL
TCR	NULL
ligation	NULL
(	NULL
10	NULL
)	NULL
.	NULL

T	NULL
cells	NULL
from	NULL
Vav-deficient	NULL
mice	NULL
do	NULL
not	NULL
respond	NULL
effectively	NULL
to	NULL
TCR	NULL
stimulation	NULL
This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
SLP-76	NULL
and	NULL
Vav	NULL
Function	NULL
in	NULL
Separate	NULL
Signaling	NULL
Pathways	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
overexpression	NULL
of	NULL
SLP-76	NULL
and	NULL
Vav	NULL
together	NULL
has	NULL
a	NULL
synergistic	NULL
effect	NULL
on	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
29	NULL
)	NULL
.	NULL

However	NULL
,	NULL
previous	NULL
studies	NULL
have	NULL
not	NULL
addressed	NULL
whether	NULL
the	NULL
interaction	NULL
between	NULL
SLP-76	NULL
and	NULL
Vav	NULL
is	NULL
required	NULL
for	NULL
their	NULL
synergy	NULL
and	NULL
if	NULL
these	NULL
two	NULL
proteins	NULL
function	NULL
in	NULL
the	NULL
same	NULL
signaling	NULL
pathways	NULL
.	NULL

In	NULL
the	NULL
experiments	NULL
described	NULL
in	NULL
this	NULL
report	NULL
we	NULL
investigated	NULL
these	NULL
questions	NULL
first	NULL
by	NULL
identifying	NULL
the	NULL
tyrosines	NULL
of	NULL
SLP-76	NULL
responsible	NULL
for	NULL
the	NULL
interaction	NULL
with	NULL
Vav	NULL
both	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
intact	NULL
Jurkat	NULL
cells	NULL
.	NULL

Using	NULL
this	NULL
information	NULL
,	NULL
we	NULL
performed	NULL
a	NULL
series	NULL
of	NULL
co-transfection	NULL
assays	NULL
and	NULL
determined	NULL
that	NULL
the	NULL
intermolecular	NULL
interaction	NULL
between	NULL
SLP-76	NULL
and	NULL
Vav	NULL
is	NULL
not	NULL
required	NULL
for	NULL
their	NULL
functional	NULL
synergy	NULL
.	NULL

This	NULL
finding	NULL
suggested	NULL
the	NULL
hypothesis	NULL
that	NULL
overexpression	NULL
of	NULL
SLP-76	NULL
versus	NULL
Vav	NULL
may	NULL
impact	NULL
distinct	NULL
signaling	NULL
pathways	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Experiments	NULL
are	NULL
presented	NULL
demonstrating	NULL
that	NULL
these	NULL
two	NULL
molecules	NULL
modulate	NULL
distinct	NULL
signaling	NULL
cascades	NULL
to	NULL
link	NULL
T	NULL
cell	NULL
surface	NULL
receptors	NULL
with	NULL
IL-2	NULL
gene	NULL
expression	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Cell	NULL
Culture	NULL
and	NULL
Antibodies-The	NULL
human	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
was	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
penicillin	NULL
(	NULL
1,000	NULL
units/m1	NULL
)	NULL
,	NULL
streptomycin	NULL
(	NULL
1,000	NULL
units/ml	NULL
)	NULL
,	NULL
and	NULL
glutamine	NULL
(	NULL
20	NULL
mM	NULL
)	NULL
.	NULL

For	NULL
stimulation	NULL
through	NULL
the	NULL
TCR	NULL
,	NULL
ascites	NULL
of	NULL
the	NULL
clonotypic	NULL
mAb	NULL
C305	NULL
(	NULL
82	NULL
)	NULL
were	NULL
used	NULL
.	NULL

Anti-CD28	NULL
monoclonal	NULL
antibody	NULL
9.3A	NULL
(	NULL
ATCC	NULL
,	NULL
Manassas	NULL
,	NULL
VA	NULL
)	NULL
was	NULL
used	NULL
for	NULL
stimulating	NULL
cells	NULL
through	NULL
CD28	NULL
.	NULL

Monoclonal	NULL
antibody	NULL
M2	NULL
recognizes	NULL
the	NULL
FLAG	NULL
epitope	NULL
(	NULL
International	NULL
Bio-technologies	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
CT	NULL
)	NULL
.	NULL

Monoclonal	NULL
antibody	NULL
9610	NULL
recognizes	NULL
the	NULL
Myc	NULL
epitope	NULL
.	NULL

Phosphotyrosine-containing	NULL
proteins	NULL
were	NULL
detected	NULL
by	NULL
the	NULL
4G10	NULL
mAb	NULL
(	NULL
Upstate	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
,	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

cDNA	NULL
Constructs	NULL
and	NULL
Fusion	NULL
Proteins-Wild-type	NULL
SLP-76	NULL
and	NULL
each	NULL
of	NULL
the	NULL
mutants	NULL
were	NULL
cloned	NULL
into	NULL
modified	NULL
pEF-BOS	NULL
vector	NULL
containing	NULL
a	NULL
sequence	NULL
encoding	NULL
the	NULL
FLAG	NULL
epitope	NULL
on	NULL
the	NULL
amino	NULL
terminus	NULL
of	NULL
the	NULL
cDNAs	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
11	NULL
,	NULL
17	NULL
)	NULL
.	NULL

cDNAs	NULL
encoding	NULL
Vav	NULL
and	NULL
ERK2	NULL
with	NULL
a	NULL
Myc	NULL
epitope	NULL
on	NULL
the	NULL
amino	NULL
terminus	NULL
were	NULL
also	NULL
cloned	NULL
into	NULL
pEF-BOS	NULL
vector	NULL
(	NULL
gifts	NULL
of	NULL
Dr.	NULL
A.	NULL
Weiss	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
NFAT	NULL
luciferase	NULL
reporter	NULL
construct	NULL
(	NULL
NFAT-luc	NULL
)	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
G.	NULL
Crabtree	NULL
(	NULL
Stanford	NULL
University	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
full-length	NULL
IL-2	NULL
promoter	NULL
driven	NULL
luciferase	NULL
construct	NULL
(	NULL
pIL-ZlucZ2kb	NULL
)	NULL
was	NULL
a	NULL
gift	NULL
of	NULL
Dr.	NULL
R.	NULL
Abraham	NULL
(	NULL
Mayo	NULL
Clinic	NULL
,	NULL
Rochester	NULL
,	NULL
MN	NULL
)	NULL
.	NULL

The	NULL
AP-1	NULL
B-Gal	NULL
construct	NULL
(	NULL
pAP-1-lacZ	NULL
)	NULL
was	NULL
a	NULL
gift	NULL
of	NULL
Dr.	NULL
D.	NULL
Mueller	NULL
(	NULL
University	NULL
of	NULL
Min-nesota	NULL
,	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
.	NULL

The	NULL
CD28RE	NULL
luciferase	NULL
construct	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
K.	NULL
L.	NULL
McGuire	NULL
(	NULL
San	NULL
Diego	NULL
State	NULL
University	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
GST	NULL
Vav	NULL
SH2	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
S.	NULL
Katzav	NULL
(	NULL
Lady	NULL
Davis	NULL
Institute	NULL
,	NULL
Jewish	NULL
General	NULL
Hospital	NULL
,	NULL
Montereal	NULL
,	NULL
Quebec	NULL
,	NULL
Canada	NULL
)	NULL
.	NULL

GST	NULL
fusion	NULL
protein	NULL
was	NULL
induced	NULL
and	NULL
affinity	NULL
purified	NULL
as	NULL
described	NULL
(	NULL
83	NULL
)	NULL
.	NULL

Transfections-For	NULL
transient	NULL
transfection	NULL
,	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
electropo-rated	NULL
at	NULL
250	NULL
V	NULL
,	NULL
960	NULL
microfarads	NULL
using	NULL
a	NULL
Gene	NULL
Pulser	NULL
(	NULL
Bio-Rad	NULL
)	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
17	NULL
)	NULL
,	NULL
with	NULL
20	NULL
ug	NULL
of	NULL
the	NULL
NFAT	NULL
,	NULL
AP-1	NULL
,	NULL
IL-2	NULL
,	NULL
or	NULL
CD28RE	NULL
reporter	NULL
plasmids	NULL
,	NULL
or	NULL
pEF-myc-ERK2	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
plasmids	NULL
encoding	NULL
Vav	NULL
or	NULL
variant	NULL
SLP-76	NULL
constructs	NULL
in	NULL
the	NULL
synergy	NULL
experiments	NULL
,	NULL
and	NULL
40	NULL
ug	NULL
of	NULL
Vav	NULL
or	NULL
SLP-76	NULL
constructs	NULL
elsewhere	NULL
.	NULL

Reporter	NULL
Assays-Luciferase	NULL
or	NULL
B-Gal	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
triplicates	NULL
of	NULL
5	NULL
X	NULL
10°	NULL
viable	NULL
cells	NULL
were	NULL
stimulated	NULL
as	NULL
indicated	NULL
at	NULL
87	NULL
°C	NULL
for	NULL
8	NULL
h	NULL
,	NULL
lysed	NULL
,	NULL
and	NULL
subsequently	NULL
assayed	NULL
for	NULL
luciferase	NULL
or	NULL
B-Gal	NULL
activity	NULL
with	NULL
a	NULL
monolight	NULL
luminometer	NULL
(	NULL
Analytical	NULL
Luminescence	NULL
Laboratory	NULL
,	NULL
Ann	NULL
Arbor	NULL
,	NULL
MI	NULL
)	NULL
.	NULL

Immunoprecipitations	NULL
,	NULL
Protein	NULL
Precipitations	NULL
,	NULL
and	NULL
Immunoblots-24	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
collected	NULL
,	NULL
washed	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
and	NULL
left	NULL
unstimulated	NULL
,	NULL
or	NULL
stimulated	NULL
with	NULL
C805	NULL
ascites	NULL
(	NULL
1:1,000	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
,	NULL
or	NULL
with	NULL
pervanadate	NULL
for	NULL
2	NULL
min	NULL
,	NULL
or	NULL
with	NULL
PMA	NULL
for	NULL
5	NULL
min	NULL
.	NULL

Lysates	NULL
were	NULL
prepared	NULL
in	NULL
Nonidet	NULL
P-40	NULL
lysis	NULL
buffer	NULL
containing	NULL
protease	NULL
and	NULL
phosphatase	NULL
inhibitors	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
9	NULL
)	NULL
,	NULL
and	NULL
precipitated	NULL
with	NULL
GST	NULL
fusion	NULL
proteins	NULL
or	NULL
indicated	NULL
antibodies	NULL
at	NULL
4	NULL
°C	NULL
for	NULL
2	NULL
h.	NULL
Following	NULL
precipitation	NULL
,	NULL
the	NULL
protein	NULL
complexes	NULL
were	NULL
washed	NULL
extensively	NULL
in	NULL
Nonidet	NULL
P-40	NULL
lysis	NULL
buffer	NULL
,	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
for	NULL
immunoblot	NULL
analysis	NULL
with	NULL
the	NULL
indicated	NULL
antibodies	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
horseradish	NULL
peroxidase-conjugated	NULL
secondary	NULL
Ab	NULL
(	NULL
Bio-Rad	NULL
)	NULL
and	NULL
developed	NULL
by	NULL
enhanced	NULL
chemiluminescence	NULL
(	NULL
ECL	NULL
;	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
.	NULL

ERK2	NULL
in	NULL
Vitro	NULL
Kinase	NULL
Activity	NULL
Assays-ERK2	NULL
kinase	NULL
activity	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
pEF	NULL
,	NULL
pEF/SLP-76	NULL
,	NULL
pEF/Vav	NULL
plus	NULL
pEF/myc/ERK2	NULL
.	NULL

24	NULL
h	NULL
later	NULL
,	NULL
transfected	NULL
cells	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
anti	NULL
TCR	NULL
mAb	NULL
C305	NULL
or	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
(	NULL
PMA	NULL
)	NULL
,	NULL
lysed	NULL
in	NULL
Triton	NULL
16207	NULL
X-100	NULL
lysis	NULL
buffer	NULL
,	NULL
and	NULL
precipitated	NULL
with	NULL
anti-Myc	NULL
antibody	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4°C	NULL
after	NULL
stimulation	NULL
,	NULL
The	NULL
anti-Myc	NULL
immune	NULL
complexes	NULL
were	NULL
washed	NULL
extensively	NULL
and	NULL
suspended	NULL
in	NULL
kinase	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
13	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
and	NULL
1.5	NULL
mM	NULL
EGTA	NULL
)	NULL
containing	NULL
myelin	NULL
basic	NULL
protein	NULL
(	NULL
MBP	NULL
,	NULL
1	NULL
mg/ml	NULL
)	NULL
and	NULL
[	NULL
y-	NULL
``	NULL
°PJATP	NULL
(	NULL
0.22	NULL
uCi/zample	NULL
)	NULL
,	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
15	NULL
min	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
.	NULL

Each	NULL
gel	NULL
was	NULL
stained	NULL
with	NULL
Coomassie	NULL
Blue	NULL
to	NULL
assure	NULL
equal	NULL
loading	NULL
of	NULL
the	NULL
MBP	NULL
substrate	NULL
and	NULL
phosphorylation	NULL
of	NULL
MBP	NULL
was	NULL
visualized	NULL
by	NULL
autoradiography	NULL
and	NULL
quantitated	NULL
by	NULL
densitometry	NULL
using	NULL
the	NULL
NIH	NULL
Image	NULL
computer	NULL
program	NULL
.	NULL

RESULTS	NULL
Both	NULL
Tyrosines	NULL
113	NULL
and	NULL
128	NULL
of	NULL
SLP-76	NULL
Are	NULL
Required	NULL
for	NULL
the	NULL
SLP-76/Vav	NULL
Interaction-The	NULL
interaction	NULL
between	NULL
SLP-76	NULL
and	NULL
Vav	NULL
depends	NULL
on	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
Vav	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
SLP-76	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Using	NULL
a	NULL
phosphopeptide	NULL
library	NULL
,	NULL
Songyang	NULL
et	NULL
al	NULL
.	NULL

(	NULL
34	NULL
)	NULL
found	NULL
that	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
Vav	NULL
preferentially	NULL
binds	NULL
phosphorylated	NULL
tyrosines	NULL
in	NULL
a	NULL
Y*XXP	NULL
motif	NULL
(	NULL
where	NULL
Y*	NULL
represents	NULL
a	NULL
phosphorylated	NULL
tyrosine	NULL
,	NULL
X	NULL
is	NULL
any	NULL
amino	NULL
acid	NULL
,	NULL
and	NULL
P	NULL
is	NULL
a	NULL
proline	NULL
residue	NULL
)	NULL
.	NULL

There	NULL
are	NULL
three	NULL
tyrosines	NULL
within	NULL
SLP-76	NULL
which	NULL
fall	NULL
into	NULL
such	NULL
a	NULL
motif	NULL
:	NULL
tyrosines	NULL
113	NULL
(	NULL
YESP	NULL
)	NULL
,	NULL
128	NULL
(	NULL
YESP	NULL
)	NULL
,	NULL
and	NULL
145	NULL
(	NULL
YEPP	NULL
)	NULL
.	NULL

Several	NULL
lines	NULL
of	NULL
evidence	NULL
suggest	NULL
that	NULL
Tyr-113	NULL
and	NULL
Tyr-128	NULL
are	NULL
good	NULL
candidates	NULL
for	NULL
mediating	NULL
the	NULL
association	NULL
between	NULL
SLP-76	NULL
and	NULL
Vav	NULL
.	NULL

First	NULL
,	NULL
both	NULL
Tyr-113	NULL
and	NULL
Tyr-128	NULL
are	NULL
substrates	NULL
of	NULL
the	NULL
TCR-stimulated	NULL
PTKs	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
a	NULL
similar	NULL
YESP	NULL
motif	NULL
found	NULL
in	NULL
both	NULL
ZAP-70	NULL
and	NULL
Syk	NULL
is	NULL
known	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
interaction	NULL
of	NULL
these	NULL
PTKs	NULL
with	NULL
Vav	NULL
(	NULL
85	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
phosphorylated	NULL
pep-tides	NULL
corresponding	NULL
to	NULL
the	NULL
two	NULL
YESP	NULL
motifs	NULL
of	NULL
SLP-76	NULL
precipitate	NULL
Vav	NULL
from	NULL
cell	NULL
lysates	NULL
and	NULL
inhibit	NULL
the	NULL
SLP-76/Vayv	NULL
interaction	NULL
in	NULL
vitro	NULL
(	NULL
28	NULL
,	NULL
37	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
further	NULL
the	NULL
importance	NULL
of	NULL
Tyr-113	NULL
,	NULL
Tyr-128	NULL
,	NULL
and	NULL
Tyr-145	NULL
in	NULL
mediating	NULL
the	NULL
interaction	NULL
between	NULL
full-length	NULL
SLP-76	NULL
and	NULL
Vav	NULL
in	NULL
intact	NULL
T	NULL
cells	NULL
,	NULL
FLAG-tagged	NULL
SLP-76	NULL
constructs	NULL
encoding	NULL
wild-type	NULL
SLP-76	NULL
(	NULL
WT	NULL
)	NULL
or	NULL
point	NULL
mutants	NULL
with	NULL
tyrosines	NULL
113	NULL
,	NULL
128	NULL
,	NULL
or	NULL
145	NULL
individually	NULL
changed	NULL
to	NULL
phenylala-nine	NULL
(	NULL
Y113F	NULL
,	NULL
Y128F	NULL
,	NULL
and	NULL
Y145F	NULL
)	NULL
were	NULL
transfected	NULL
into	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
stimulated	NULL
via	NULL
their	NULL
TCR	NULL
,	NULL
lysed	NULL
,	NULL
and	NULL
precipitated	NULL
with	NULL
anti-FLAG	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
or	NULL
GST-Vav-SH2	NULL
fusion	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Each	NULL
construct	NULL
was	NULL
expressed	NULL
at	NULL
similar	NULL
levels	NULL
as	NULL
revealed	NULL
by	NULL
immunoblot	NULL
analysis	NULL
for	NULL
the	NULL
FLAG	NULL
epitope	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A	NULL
,	NULL
top	NULL
panel	NULL
;	NULL
B	NULL
,	NULL
left	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
previously	NULL
,	NULL
wild-type	NULL
SLP-76	NULL
and	NULL
each	NULL
single	NULL
tyrosine	NULL
mutant	NULL
is	NULL
phosphorylated	NULL
upon	NULL
TCR	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
bottom	NULL
panel	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
however	NULL
,	NULL
mutation	NULL
of	NULL
either	NULL
Tyr-113	NULL
or	NULL
Tyr-128	NULL
abrogates	NULL
the	NULL
binding	NULL
of	NULL
SLP-76	NULL
to	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
Vav	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
wild-type	NULL
SLP-76	NULL
and	NULL
the	NULL
Y145F	NULL
mutant	NULL
still	NULL
bind	NULL
to	NULL
the	NULL
Vav-SH2	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

To	NULL
obtain	NULL
optimal	NULL
phosphorylation	NULL
of	NULL
SLP-76	NULL
,	NULL
we	NULL
also	NULL
stimulated	NULL
cells	NULL
with	NULL
pervanadate	NULL
,	NULL
a	NULL
tyrosine	NULL
phosphatase	NULL
inhibitor	NULL
and	NULL
found	NULL
again	NULL
that	NULL
the	NULL
Y113F	NULL
and	NULL
Y128F	NULL
SLP-76	NULL
mutants	NULL
fail	NULL
to	NULL
associate	NULL
with	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
Vav	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
in	NULL
vitro	NULL
findings	NULL
were	NULL
followed	NULL
by	NULL
experiments	NULL
in	NULL
intact	NULL
Jurkat	NULL
cells	NULL
.	NULL

For	NULL
these	NULL
studies	NULL
,	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
Myc-tagged	NULL
Vav	NULL
and	NULL
FLAG-tagged	NULL
SLP-76	NULL
constructs	NULL
.	NULL

Transfected	NULL
Jurkat	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
pervanadate	NULL
,	NULL
lysed	NULL
,	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
anti-Myc	NULL
antibody	NULL
.	NULL

As	NULL
shown	NULL
,	NULL
an	NULL
equal	NULL
amount	NULL
of	NULL
Vav	NULL
is	NULL
present	NULL
in	NULL
each	NULL
immune	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
top	NULL
panel	NULL
)	NULL
.	NULL

However	NULL
,	NULL
both	NULL
SLP-76	NULL
mutants	NULL
Y113F	NULL
and	NULL
Y128F	NULL
fail	NULL
to	NULL
co-immunoprecipitate	NULL
with	NULL
Myc-Vav	NULL
,	NULL
while	NULL
wild-type	NULL
SLP-76	NULL
and	NULL
the	NULL
Y145F	NULL
mutant	NULL
associate	NULL
with	NULL
Vav	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
bottom	NULL
panel	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
our	NULL
in	NULL
vitro	NULL
finding	NULL
,	NULL
both	NULL
tyrosines	NULL
113	NULL
and	NULL
128	NULL
of	NULL
SLP-76	NULL
are	NULL
required	NULL
for	NULL
the	NULL
association	NULL
of	NULL
SLP-76	NULL
with	NULL
the	NULL
Vav	NULL
SH2	NULL
in	NULL
intact	NULL
cells	NULL
.	NULL

Synergy	NULL
between	NULL
Vav	NULL
and	NULL
SLP-76	NULL
Does	NULL
Not	NULL
Require	NULL
Their	NULL
Interaction-Although	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
SLP-76	NULL
and	NULL
Vav	NULL
syner-gize	NULL
to	NULL
couple	NULL
TCR	NULL
ligation	NULL
with	NULL
cytokine	NULL
gene	NULL
expression	NULL
(	NULL
29	NULL
)	NULL
,	NULL
the	NULL
mechanism	NULL
for	NULL
this	NULL
cooperation	NULL
is	NULL
not	NULL
clear	NULL
.	NULL

One	NULL
possibility	NULL
is	NULL
that	NULL
SLP-76	NULL
,	NULL
as	NULL
an	NULL
adaptor	NULL
molecule	NULL
,	NULL
recruits	NULL
Vav	NULL
to	NULL
the	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
16208	NULL
A	NULL
IP	NULL
:	NULL
anti-FLAG	NULL
[	NULL
I	NULL
$	NULL
&	NULL
«	NULL
$	NULL
®	NULL
ﬁtﬁ	NULL
81	NULL
kDa	NULL
--	NULL
an	NULL
«	NULL
-	NULL
»	NULL
an	NULL
an	NULL
Blot	NULL
:	NULL
anti-FLAG	NULL
81	NULL
kDa	NULL
--	NULL
-.-_.-	NULL
Blot	NULL
:	NULL
anti-PY	NULL
B	NULL
Lysate	NULL
Vav	NULL
SH2	NULL
PPT	NULL
[	NULL
HT	NULL
€	NULL
¢	NULL
$	NULL
x*	NULL
P	NULL
&	NULL
[	NULL
s	NULL
C	NULL
«	NULL
<	NULL
<	NULL
``	NULL
a*	NULL
¢	NULL
@	NULL
ﬁé	NULL
‘	NULL
p	NULL
‘	NULL
ﬁ	NULL
81	NULL
kDa	NULL
--	NULL
an	NULL
«	NULL
-	NULL
&	NULL
ao	NULL
&	NULL
cam	NULL
»	NULL
4-	NULL
SLP-76	NULL
Blot	NULL
:	NULL
anti-F	NULL
LAG	NULL
C	NULL
Lysates	NULL
myc-IP	NULL
I	NULL
l	NULL
I	NULL
I	NULL
&	NULL
#	NULL
&	NULL
xP	NULL
&	NULL
«	NULL
&	NULL
C	NULL
~	NULL
$	NULL
52.5	NULL
_C	NULL
ﬁvbﬁ	NULL
104	NULL
KDa	NULL
--	NULL
<	NULL
-w-	NULL
<	NULL
--	NULL
--	NULL
--	NULL
@	NULL
ames	NULL
que	NULL
CP	NULL
Vav	NULL
Blot	NULL
:	NULL
anti-myc	NULL
81	NULL
KDa	NULL
*-	NULL
_	NULL
*-	NULL
SLP-76	NULL
Blot	NULL
:	NULL
anti-F	NULL
LAG	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Tyrosines	NULL
113	NULL
and	NULL
128	NULL
of	NULL
SLP-76	NULL
are	NULL
required	NULL
for	NULL
the	NULL
association	NULL
between	NULL
SLP-76	NULL
and	NULL
Vav	NULL
.	NULL

A	NULL
and	NULL
B	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
FLAG-tagged	NULL
WT	NULL
SLP-76	NULL
and	NULL
SLP-76	NULL
mutants	NULL
Y118F	NULL
,	NULL
Y128F	NULL
,	NULL
and	NULL
Y145F	NULL
.	NULL

24	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
transfected	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
anti-TCR	NULL
mAb	NULL
C805	NULL
,	NULL
lysed	NULL
,	NULL
and	NULL
precipitated	NULL
by	NULL
either	NULL
anti-FLAG	NULL
antibody	NULL
(	NULL
A	NULL
)	NULL
or	NULL
GST-Vav	NULL
SH2	NULL
fusion	NULL
protein	NULL
(	NULL
B	NULL
)	NULL
.	NULL

In	NULL
panel	NULL
A	NULL
,	NULL
the	NULL
anti-FLAG	NULL
immune	NULL
complexes	NULL
were	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
and	NULL
Western	NULL
blotting	NULL
with	NULL
either	NULL
anti-FLAG	NULL
antibody	NULL
(	NULL
fop	NULL
)	NULL
or	NULL
anti-phospho-tyrosine	NULL
antibody	NULL
4G10	NULL
(	NULL
bottom	NULL
)	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
wild-type	NULL
SLP-76	NULL
;	NULL
Lane	NULL
2	NULL
,	NULL
Y113F	NULL
;	NULL
Lane	NULL
3	NULL
,	NULL
Y128F	NULL
;	NULL
Lane	NULL
4	NULL
,	NULL
Y145F	NULL
.	NULL

In	NULL
panel	NULL
B	NULL
,	NULL
cell	NULL
lysates	NULL
(	NULL
Lanes	NULL
1-4	NULL
)	NULL
and	NULL
GST-Vav	NULL
SH2	NULL
precipitates	NULL
(	NULL
Lanes	NULL
5-8	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
and	NULL
immunoblot	NULL
analysis	NULL
with	NULL
anti-FLAG	NULL
.	NULL

Lanes	NULL
1	NULL
and	NULL
5	NULL
,	NULL
WT	NULL
SLP-76	NULL
;	NULL
Lanes	NULL
2	NULL
and	NULL
6	NULL
,	NULL
Y113F	NULL
;	NULL
Lanes	NULL
3	NULL
and	NULL
7	NULL
,	NULL
Y128F	NULL
;	NULL
Lanes	NULL
4	NULL
and	NULL
8	NULL
,	NULL
Y145F	NULL
.	NULL

C	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
Myc-tagged	NULL
Vav	NULL
and	NULL
FLAG-tagged	NULL
SLP-76	NULL
WT	NULL
or	NULL
mutant	NULL
constructs	NULL
.	NULL

24	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
pervanadate	NULL
,	NULL
lysed	NULL
,	NULL
and	NULL
precipitated	NULL
with	NULL
anti-Myc	NULL
antibody	NULL
.	NULL

Cell	NULL
lysates	NULL
(	NULL
Lanes	NULL
1-4	NULL
)	NULL
and	NULL
anti-Myc	NULL
immuno-complexes	NULL
(	NULL
Lanes	NULL
5-8	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
and	NULL
blotted	NULL
with	NULL
anti-Myc	NULL
antibody	NULL
(	NULL
top	NULL
)	NULL
or	NULL
anti-FLAG	NULL
antibody	NULL
(	NULL
Gboffom	NULL
)	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Lanes	NULL
1	NULL
and	NULL
5	NULL
,	NULL
cells	NULL
transfected	NULL
with	NULL
WT	NULL
SLP-76	NULL
;	NULL
Lanes	NULL
2	NULL
and	NULL
6	NULL
,	NULL
Y1183F	NULL
;	NULL
Lanes	NULL
3	NULL
and	NULL
7	NULL
,	NULL
Y128F	NULL
;	NULL
Lanes	NULL
4	NULL
and	NULL
8	NULL
,	NULL
Y145F	NULL
.	NULL

proper	NULL
subcellular	NULL
location	NULL
where	NULL
Vav	NULL
executes	NULL
its	NULL
role	NULL
as	NULL
a	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
factor	NULL
.	NULL

If	NULL
this	NULL
were	NULL
true	NULL
,	NULL
the	NULL
synergy	NULL
between	NULL
SLP-76	NULL
and	NULL
Vav	NULL
should	NULL
require	NULL
their	NULL
interaction	NULL
.	NULL

To	NULL
test	NULL
this	NULL
possibility	NULL
,	NULL
we	NULL
transfected	NULL
cDNA	NULL
encoding	NULL
Vav	NULL
along	NULL
with	NULL
SLP-76	NULL
mutants	NULL
Y113F	NULL
and	NULL
Y128F	NULL
and	NULL
assessed	NULL
the	NULL
effect	NULL
on	NULL
IL-2-NFAT	NULL
promoter	NULL
activity	NULL
.	NULL

To	NULL
optimize	NULL
conditions	NULL
for	NULL
observing	NULL
synergy	NULL
between	NULL
SLP-76	NULL
and	NULL
Vav	NULL
,	NULL
limiting	NULL
amounts	NULL
of	NULL
cDNA	NULL
encoding	NULL
SLP-76	NULL
and	NULL
Vav	NULL
were	NULL
transfected	NULL
into	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
,	NULL
overexpression	NULL
of	NULL
SLP-76	NULL
or	NULL
Vav	NULL
alone	NULL
at	NULL
this	NULL
level	NULL
fails	NULL
to	NULL
augment	NULL
IL-2-NFAT	NULL
promoter	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
co-transfection	NULL
of	NULL
Vav	NULL
with	NULL
wild-type	NULL
SLP-76	NULL
,	NULL
or	NULL
either	NULL
SLP-76/Y113F	NULL
or	NULL
SLP-76/Y128F	NULL
augments	NULL
IL-2-NFAT	NULL
promoter	NULL
activity	NULL
significantly	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

In	NULL
each	NULL
experiment	NULL
,	NULL
Western	NULL
blot	NULL
analysis	NULL
demonstrated	NULL
that	NULL
all	NULL
of	NULL
the	NULL
SLP-76	NULL
constructs	NULL
were	NULL
expressed	NULL
at	NULL
similar	NULL
levels	NULL
and	NULL
that	NULL
Vav	NULL
was	NULL
expressed	NULL
similarly	NULL
in	NULL
each	NULL
transfection	NULL
condition	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
SLP-76	NULL
,	NULL
but	NULL
Not	NULL
Vav	NULL
,	NULL
Augments	NULL
TCR-in-	NULL
SLP-76	NULL
and	NULL
Vav	NULL
Function	NULL
in	NULL
Separate	NULL
Signaling	NULL
Pathways	NULL
|	NULL
Parcentage	NULL
of	NULL
Maximum	NULL
s	NULL
n	NULL
&	NULL
a	NULL
e	NULL
3	NULL
R	NULL
&	NULL
R	NULL
8	NULL
vsrar	NULL
Ine	NULL
“	NULL
Vb	NULL
4	NULL
]	NULL
o	NULL
~~	NULL
h	NULL
O	NULL
o	NULL
B	NULL
§	NULL
%	NULL
&	NULL
i	NULL
&	NULL
Ee	NULL
F	NULL
F	NULL
F	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

The	NULL
synergy	NULL
between	NULL
SLP-76	NULL
and	NULL
Vav	NULL
does	NULL
not	NULL
require	NULL
their	NULL
interaction	NULL
.	NULL

A	NULL
luciferase	NULL
reporter	NULL
construct	NULL
driven	NULL
by	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
NFAT	NULL
element	NULL
of	NULL
IL-2	NULL
promoter	NULL
was	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
alone	NULL
with	NULL
control	NULL
vector	NULL
or	NULL
cDNA	NULL
encoding	NULL
SLP-76	NULL
(	NULL
WT	NULL
,	NULL
Y113F	NULL
,	NULL
Y128F	NULL
,	NULL
and	NULL
Y145F	NULL
)	NULL
,	NULL
Vav	NULL
,	NULL
or	NULL
SLP-76	NULL
plus	NULL
Vav	NULL
.	NULL

24	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
UN	NULL
;	NULL
C	NULL
]	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
anti-TCR	NULL
mAb	NULL
C305	NULL
(	NULL
TCR	NULL
,	NULL
;	NULL
)	NULL
or	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
8	NULL
h.	NULL
Lysates	NULL
were	NULL
prepared	NULL
and	NULL
analyzed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

Results	NULL
are	NULL
shown	NULL
as	NULL
the	NULL
percentage	NULL
of	NULL
the	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
response	NULL
(	NULL
maximum	NULL
)	NULL
for	NULL
each	NULL
group	NULL
.	NULL

Expression	NULL
of	NULL
SLP-76	NULL
constructs	NULL
and	NULL
Vav	NULL
constructs	NULL
were	NULL
documented	NULL
by	NULL
Western	NULL
analysis	NULL
.	NULL

SLP-76	NULL
expression	NULL
level	NULL
is	NULL
not	NULL
changed	NULL
with	NULL
co-overexpression	NULL
of	NULL
Vav	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

duced	NULL
AP-1	NULL
Activity-Our	NULL
observation	NULL
that	NULL
the	NULL
association	NULL
between	NULL
SLP-76	NULL
and	NULL
Vav	NULL
is	NULL
not	NULL
required	NULL
for	NULL
their	NULL
functional	NULL
cooperation	NULL
suggests	NULL
the	NULL
possibility	NULL
that	NULL
these	NULL
two	NULL
proteins	NULL
modulate	NULL
different	NULL
TCR-induced	NULL
signaling	NULL
cascades	NULL
.	NULL

We	NULL
and	NULL
others	NULL
have	NULL
found	NULL
that	NULL
when	NULL
overexpressed	NULL
individually	NULL
,	NULL
both	NULL
SLP-76	NULL
and	NULL
Vav	NULL
augment	NULL
activity	NULL
of	NULL
the	NULL
NFAT	NULL
region	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

Work	NULL
from	NULL
several	NULL
laboratories	NULL
has	NULL
shown	NULL
that	NULL
this	NULL
region	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
includes	NULL
two	NULL
com-ponents	NULL
;	NULL
a	NULL
sequence	NULL
which	NULL
binds	NULL
NFAT	NULL
family	NULL
members	NULL
and	NULL
a	NULL
contiguous	NULL
region	NULL
which	NULL
binds	NULL
AP-1	NULL
dimers	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

38	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
modulating	NULL
signals	NULL
leading	NULL
to	NULL
either	NULL
NFAT	NULL
translocation	NULL
and	NULL
activity	NULL
or	NULL
AP-1	NULL
function	NULL
could	NULL
increase	NULL
responsiveness	NULL
of	NULL
an	NULL
IL-2	NULL
promoter-derived	NULL
NFAT	NULL
reporter	NULL
(	NULL
39-41	NULL
)	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
in	NULL
the	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
,	NULL
SLP-76	NULL
overexpression	NULL
augments	NULL
TCR-induced	NULL
activation	NULL
of	NULL
a	NULL
B-galactosid-ase	NULL
reporter	NULL
driven	NULL
by	NULL
5	NULL
copies	NULL
of	NULL
an	NULL
AP-1	NULL
response	NULL
element	NULL
(	NULL
17	NULL
)	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
overexpression	NULL
of	NULL
Vav	NULL
has	NULL
a	NULL
similar	NULL
impact	NULL
on	NULL
AP-1	NULL
function	NULL
,	NULL
we	NULL
transfected	NULL
Jurkat	NULL
cells	NULL
with	NULL
the	NULL
AP-1	NULL
reporter	NULL
construct	NULL
along	NULL
with	NULL
either	NULL
SLP-76	NULL
or	NULL
Vav	NULL
and	NULL
measured	NULL
-galactosidase	NULL
activity	NULL
in	NULL
resting	NULL
and	NULL
stimulated	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
TCR	NULL
or	NULL
PMA	NULL
stimulation	NULL
results	NULL
in	NULL
only	NULL
a	NULL
modest	NULL
increase	NULL
in	NULL
AP-1	NULL
reporter	NULL
activity	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
vector	NULL
control	NULL
.	NULL

TCR	NULL
stimulation	NULL
of	NULL
cells	NULL
transfected	NULL
with	NULL
SLP-76	NULL
cDNA	NULL
results	NULL
in	NULL
marked	NULL
augmentation	NULL
of	NULL
reporter	NULL
activity	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
SLP-76	NULL
overexpression	NULL
does	NULL
not	NULL
impact	NULL
on	NULL
PMA-stimulated	NULL
AP-1	NULL
function	NULL
as	NULL
SLP-76	NULL
is	NULL
not	NULL
tyrosine	NULL
phosphorylated	NULL
following	NULL
PMA	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
results	NULL
seen	NULL
with	NULL
SLP-76	NULL
,	NULL
overexpression	NULL
of	NULL
Vav	NULL
does	NULL
not	NULL
increase	NULL
TCR	NULL
stimulated	NULL
AP-1	NULL
activity	NULL
above	NULL
that	NULL
seen	NULL
with	NULL
the	NULL
vector	NULL
transfected	NULL
control	NULL
cells	NULL
.	NULL

Thus	NULL
it	NULL
appears	NULL
that	NULL
although	NULL
both	NULL
SLP-76	NULL
and	NULL
Vav	NULL
can	NULL
modulate	NULL
some	NULL
TCR	NULL
signals	NULL
,	NULL
those	NULL
leading	NULL
to	NULL
AP-1	NULL
activation	NULL
are	NULL
affected	NULL
by	NULL
SLP-76	NULL
but	NULL
not	NULL
Vav	NULL
.	NULL

SLP-76	NULL
,	NULL
but	NULL
Not	NULL
Vav	NULL
,	NULL
Leads	NULL
to	NULL
ERK	NULL
Activation-There	NULL
is	NULL
considerable	NULL
evidence	NULL
to	NULL
suggest	NULL
that	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
(	NULL
ERK	NULL
)	NULL
family	NULL
members	NULL
stimulated	NULL
by	NULL
TCR	NULL
ligation	NULL
function	NULL
upstream	NULL
of	NULL
AP-1	NULL
activation	NULL
(	NULL
40	NULL
,	NULL
42	NULL
,	NULL
43	NULL
)	NULL
.	NULL

We	NULL
have	NULL
found	NULL
previously	NULL
that	NULL
overexpression	NULL
of	NULL
SLP-76	NULL
augments	NULL
TCR	NULL
induced	NULL
activity	NULL
of	NULL
ERK2	NULL
(	NULL
17	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
if	NULL
Vav	NULL
has	NULL
a	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
SLP-76	NULL
and	NULL
Vav	NULL
Function	NULL
in	NULL
Separate	NULL
Signaling	NULL
Pathways	NULL
AP-1	NULL
Activity	NULL
[	NULL
]	NULL
un	NULL
10000-	NULL
[	NULL
q	NULL
]	NULL
ToR	NULL
S000	NULL
m	NULL
PMA	NULL
#	NULL
000	NULL
7000	NULL
-|	NULL
4000	NULL
Relative	NULL
Counts	NULL
§	NULL
3000	NULL
2000	NULL
1000	NULL
Vector	NULL
SLP-76	NULL
Vav	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Overexpression	NULL
of	NULL
SLP-76	NULL
,	NULL
but	NULL
not	NULL
Vav	NULL
,	NULL
augments	NULL
AP-1	NULL
activity	NULL
.	NULL

An	NULL
AP-1-68-Gal	NULL
reporter	NULL
construct	NULL
plus	NULL
a	NULL
Rous	NULL
sarcoma	NULL
virus-luciferase	NULL
construct	NULL
were	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
along	NULL
with	NULL
control	NULL
vector	NULL
,	NULL
or	NULL
cDNA	NULL
encoding	NULL
SLP-76	NULL
or	NULL
Vav	NULL
.	NULL

24	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
UN	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
anti-TCR	NULL
mAb	NULL
C805	NULL
(	NULL
TCR	NULL
)	NULL
or	NULL
PMA	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
8	NULL
h.	NULL
Cells	NULL
were	NULL
then	NULL
lysed	NULL
and	NULL
B-Gal	NULL
activity	NULL
measured	NULL
.	NULL

The	NULL
B-Gal	NULL
counts	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
Rous	NULL
sarcoma	NULL
virus-luciferase	NULL
counts	NULL
to	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

Expression	NULL
of	NULL
transfected	NULL
SLP-76	NULL
or	NULL
Vav	NULL
was	NULL
documented	NULL
by	NULL
Western	NULL
analysis	NULL
with	NULL
anti-FLAG	NULL
(	NULL
for	NULL
SLP-76	NULL
)	NULL
or	NULL
anti-Myc	NULL
(	NULL
for	NULL
Vav	NULL
)	NULL
antibody	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
experiment	NULL
is	NULL
representative	NULL
of	NULL
five	NULL
independent	NULL
experi-	NULL
ments	NULL
.	NULL

J	NULL
,	NULL
UN	NULL
;	NULL
#	NULL
,	NULL
TCR	NULL
;	NULL
M	NULL
,	NULL
PMA	NULL
.	NULL

similar	NULL
ability	NULL
to	NULL
modulate	NULL
TCR-stimulated	NULL
ERK	NULL
function	NULL
,	NULL
a	NULL
Myc-tagged	NULL
ERK2	NULL
construct	NULL
was	NULL
co-transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
along	NULL
with	NULL
cDNA	NULL
encoding	NULL
SLP-76	NULL
or	NULL
Vav	NULL
.	NULL

Cells	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
via	NULL
the	NULL
TCR	NULL
or	NULL
PMA	NULL
.	NULL

Cellular	NULL
lysates	NULL
were	NULL
then	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
with	NULL
anti-Myc	NULL
and	NULL
in	NULL
vitro	NULL
kinase	NULL
assays	NULL
were	NULL
performed	NULL
on	NULL
each	NULL
immune	NULL
complex	NULL
using	NULL
MBP	NULL
as	NULL
an	NULL
artificial	NULL
substrate	NULL
.	NULL

Phosphorylation	NULL
of	NULL
MBP	NULL
was	NULL
quantitated	NULL
by	NULL
densitometry	NULL
and	NULL
normalized	NULL
to	NULL
PMA-induced	NULL
MBP	NULL
phosphorylation	NULL
.	NULL

Whereas	NULL
overexpression	NULL
of	NULL
SLP-76	NULL
consistently	NULL
enhances	NULL
TCR-induced	NULL
kinase	NULL
activity	NULL
of	NULL
ERK2	NULL
to	NULL
a	NULL
modest	NULL
degree	NULL
,	NULL
overexpression	NULL
of	NULL
Vav	NULL
does	NULL
not	NULL
affect	NULL
ERK2	NULL
enzymatic	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
reasoned	NULL
that	NULL
if	NULL
SLP-76	NULL
affects	NULL
AP-1	NULL
indirectly	NULL
via	NULL
augmentation	NULL
of	NULL
ERK	NULL
activity	NULL
,	NULL
overexpression	NULL
of	NULL
SLP-76	NULL
and	NULL
ERK	NULL
together	NULL
should	NULL
lead	NULL
to	NULL
additive	NULL
enhancement	NULL
of	NULL
AP-1	NULL
activity	NULL
in	NULL
TCR-	NULL
,	NULL
but	NULL
not	NULL
PMA-stimulated	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
since	NULL
Vav	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
modulate	NULL
TCR-stimulated	NULL
ERK2	NULL
,	NULL
we	NULL
reasoned	NULL
that	NULL
overexpression	NULL
of	NULL
Vav	NULL
plus	NULL
ERK2	NULL
would	NULL
not	NULL
result	NULL
in	NULL
AP-1	NULL
function	NULL
above	NULL
that	NULL
seen	NULL
with	NULL
overexpression	NULL
of	NULL
ERK2	NULL
alone	NULL
.	NULL

We	NULL
tested	NULL
these	NULL
hypotheses	NULL
in	NULL
the	NULL
experiments	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

For	NULL
this	NULL
study	NULL
,	NULL
the	NULL
AP-1	NULL
reporter	NULL
construct	NULL
was	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
along	NULL
with	NULL
cDNAs	NULL
for	NULL
ERK2	NULL
alone	NULL
or	NULL
with	NULL
either	NULL
SLP-76	NULL
or	NULL
Vav	NULL
.	NULL

As	NULL
predicted	NULL
,	NULL
overexpression	NULL
of	NULL
ERK2	NULL
,	NULL
but	NULL
not	NULL
SLP-76	NULL
,	NULL
impacts	NULL
PMA-stimulated	NULL
AP-1	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
overexpression	NULL
of	NULL
either	NULL
SLP-76	NULL
or	NULL
ERK2	NULL
augments	NULL
TCR-induced	NULL
AP-1	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
our	NULL
hypothesis	NULL
,	NULL
overexpression	NULL
of	NULL
the	NULL
two	NULL
molecules	NULL
together	NULL
leads	NULL
to	NULL
further	NULL
augmentation	NULL
of	NULL
AP-1	NULL
activity	NULL
in	NULL
TCR-stimulated	NULL
Jurkat	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
when	NULL
we	NULL
perform	NULL
the	NULL
same	NULL
AP-1	NULL
reporter	NULL
analysis	NULL
in	NULL
lysates	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
Vav	NULL
,	NULL
we	NULL
find	NULL
no	NULL
augmentation	NULL
of	NULL
promoter	NULL
activity	NULL
above	NULL
that	NULL
seen	NULL
with	NULL
vector	NULL
control	NULL
transfectants	NULL
.	NULL

Additionally	NULL
,	NULL
transfection	NULL
with	NULL
Vav	NULL
plus	NULL
ERK2	NULL
provides	NULL
no	NULL
greater	NULL
AP-1	NULL
response	NULL
than	NULL
transfection	NULL
with	NULL
ERK2	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

For	NULL
each	NULL
experiment	NULL
,	NULL
Western	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
and	NULL
showed	NULL
expression	NULL
of	NULL
Myc-tagged	NULL
ERK2	NULL
and	NULL
Vav	NULL
,	NULL
or	NULL
FLAG-tagged	NULL
SLP-76	NULL
constructs	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Vav	NULL
,	NULL
but	NULL
Not	NULL
SLP-76	NULL
,	NULL
Augments	NULL
CD28-induced	NULL
IL-2	NULL
Promoter	NULL
Activity-Our	NULL
experiments	NULL
assessing	NULL
the	NULL
effect	NULL
of	NULL
SLP-76	NULL
or	NULL
Vav	NULL
on	NULL
ERK	NULL
and	NULL
AP-1	NULL
indicate	NULL
that	NULL
SLP-76	NULL
modulates	NULL
TCR-induced	NULL
signaling	NULL
pathways	NULL
which	NULL
are	NULL
not	NULL
affected	NULL
by	NULL
16209	NULL
Vav	NULL
.	NULL

We	NULL
wondered	NULL
,	NULL
therefore	NULL
,	NULL
if	NULL
the	NULL
converse	NULL
is	NULL
true	NULL
as	NULL
well	NULL
.	NULL

In	NULL
T	NULL
cells	NULL
,	NULL
signals	NULL
initiated	NULL
from	NULL
the	NULL
TCR	NULL
cooperate	NULL
with	NULL
those	NULL
arising	NULL
from	NULL
co-receptors	NULL
,	NULL
such	NULL
as	NULL
CD28	NULL
,	NULL
to	NULL
optimize	NULL
IL-2	NULL
gene	NULL
transcription	NULL
(	NULL
44	NULL
,	NULL
45	NULL
)	NULL
.	NULL

Work	NULL
from	NULL
a	NULL
number	NULL
of	NULL
investigators	NULL
has	NULL
shown	NULL
that	NULL
the	NULL
TCR	NULL
and	NULL
CD28	NULL
stimulate	NULL
transactivation	NULL
of	NULL
different	NULL
regions	NULL
within	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
46-48	NULL
)	NULL
.	NULL

A	NULL
CD28-response	NULL
element	NULL
within	NULL
the	NULL
IL-2	NULL
promoter	NULL
,	NULL
CD28RE	NULL
,	NULL
has	NULL
been	NULL
defined	NULL
which	NULL
contains	NULL
binding	NULL
sites	NULL
for	NULL
Rel	NULL
family	NULL
members	NULL
in	NULL
conjunction	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
(	NULL
48-50	NULL
)	NULL
.	NULL

In	NULL
combination	NULL
with	NULL
TCR	NULL
ligation	NULL
or	NULL
mitogenic	NULL
stimulators	NULL
such	NULL
as	NULL
PMA	NULL
or	NULL
phytohemagglutinin	NULL
,	NULL
engagement	NULL
of	NULL
CD28	NULL
induces	NULL
these	NULL
transcription	NULL
factors	NULL
to	NULL
bind	NULL
to	NULL
and	NULL
transactivate	NULL
the	NULL
CD2SRE	NULL
(	NULL
48	NULL
,	NULL
49	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
potential	NULL
roles	NULL
of	NULL
SLP-76	NULL
and	NULL
Vav	NULL
in	NULL
CD28-stimulated	NULL
IL-2	NULL
transcription	NULL
,	NULL
we	NULL
performed	NULL
reporter	NULL
assays	NULL
using	NULL
either	NULL
a	NULL
full-length	NULL
IL-2	NULL
promoter	NULL
construct	NULL
(	NULL
which	NULL
includes	NULL
the	NULL
CD28RE	NULL
)	NULL
or	NULL
a	NULL
reporter	NULL
construct	NULL
driven	NULL
by	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
CD28RE	NULL
.	NULL

The	NULL
full-length	NULL
IL-2	NULL
promoter	NULL
construct	NULL
was	NULL
co-transfected	NULL
into	NULL
Jurkat	NULL
T	NULL
cells	NULL
with	NULL
cDNAs	NULL
encoding	NULL
either	NULL
SLP-76	NULL
or	NULL
Vav	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
then	NULL
left	NULL
untreated	NULL
or	NULL
treated	NULL
with	NULL
TCR	NULL
plus	NULL
PMA	NULL
or	NULL
CD28	NULL
plus	NULL
PMA	NULL
.	NULL

As	NULL
shown	NULL
,	NULL
although	NULL
overexpression	NULL
of	NULL
either	NULL
SLP-76	NULL
or	NULL
Vav	NULL
augments	NULL
IL-2	NULL
promoter	NULL
activity	NULL
induced	NULL
by	NULL
stimulation	NULL
via	NULL
the	NULL
TCR	NULL
plus	NULL
PMA	NULL
,	NULL
overexpression	NULL
of	NULL
Vav	NULL
but	NULL
not	NULL
SLP-76	NULL
augments	NULL
the	NULL
CD28	NULL
plus	NULL
PMA	NULL
signal	NULL
.	NULL

PMA	NULL
by	NULL
itself	NULL
is	NULL
not	NULL
able	NULL
to	NULL
induce	NULL
IL-2	NULL
promoter	NULL
activity	NULL
and	NULL
overexpression	NULL
of	NULL
either	NULL
Vav	NULL
or	NULL
SLP-76	NULL
does	NULL
not	NULL
affect	NULL
its	NULL
function	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
Vav	NULL
,	NULL
but	NULL
not	NULL
SLP-76	NULL
,	NULL
can	NULL
mediate	NULL
the	NULL
signaling	NULL
pathways	NULL
linking	NULL
CD28	NULL
to	NULL
IL-2	NULL
gene	NULL
expression	NULL
.	NULL

Expression	NULL
of	NULL
transfected	NULL
Vav	NULL
or	NULL
SLP-76	NULL
constructs	NULL
were	NULL
verified	NULL
by	NULL
Western	NULL
blot	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
test	NULL
more	NULL
directly	NULL
whether	NULL
Vav	NULL
can	NULL
regulate	NULL
CD28RE	NULL
activation	NULL
following	NULL
CD28	NULL
ligation	NULL
,	NULL
we	NULL
performed	NULL
experiments	NULL
with	NULL
the	NULL
CD28RE	NULL
reporter	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
this	NULL
reporter	NULL
along	NULL
with	NULL
a	NULL
vector	NULL
control	NULL
,	NULL
SLP-76	NULL
,	NULL
or	NULL
Vav	NULL
.	NULL

Cells	NULL
were	NULL
left	NULL
untreated	NULL
or	NULL
were	NULL
stimulated	NULL
via	NULL
their	NULL
TCR	NULL
or	NULL
with	NULL
anti-CD28	NULL
plus	NULL
PMA	NULL
.	NULL

Consistent	NULL
with	NULL
previous	NULL
findings	NULL
of	NULL
others	NULL
(	NULL
48	NULL
,	NULL
50	NULL
)	NULL
,	NULL
TCR	NULL
stimulation	NULL
or	NULL
PMA	NULL
by	NULL
itself	NULL
fails	NULL
to	NULL
induce	NULL
CD28RE	NULL
activity	NULL
in	NULL
vector	NULL
control	NULL
transfectants	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
we	NULL
find	NULL
that	NULL
overexpression	NULL
of	NULL
neither	NULL
SLP-76	NULL
nor	NULL
Vav	NULL
modifies	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
TCR	NULL
or	NULL
PMA	NULL
to	NULL
induce	NULL
this	NULL
reporter	NULL
.	NULL

Interestingly	NULL
,	NULL
however	NULL
,	NULL
transfection	NULL
of	NULL
Vav	NULL
,	NULL
but	NULL
not	NULL
SLP-76	NULL
,	NULL
augments	NULL
CD28/PMA-induced	NULL
CD28RE	NULL
activation	NULL
,	NULL
again	NULL
supporting	NULL
the	NULL
notion	NULL
that	NULL
Vav	NULL
and	NULL
SLP-76	NULL
differ	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
impact	NULL
on	NULL
CD28-stimulated	NULL
signaling	NULL
pathways	NULL
.	NULL

DISCUSSION	NULL
Numerous	NULL
signaling	NULL
cascades	NULL
function	NULL
together	NULL
to	NULL
link	NULL
antigen	NULL
recognition	NULL
to	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Recently	NULL
,	NULL
a	NULL
number	NULL
of	NULL
studies	NULL
have	NULL
demonstrated	NULL
the	NULL
importance	NULL
of	NULL
adaptor	NULL
molecules	NULL
in	NULL
regulating	NULL
this	NULL
network	NULL
(	NULL
reviewed	NULL
in	NULL
Refs	NULL
.	NULL

51-54	NULL
)	NULL
.	NULL

Having	NULL
no	NULL
intrinsic	NULL
enzymatic	NULL
activity	NULL
,	NULL
adaptor	NULL
molecules	NULL
recruit	NULL
other	NULL
signaling	NULL
proteins	NULL
to	NULL
form	NULL
multimeric	NULL
complexes	NULL
through	NULL
intermolecular	NULL
associations	NULL
.	NULL

SLP-76	NULL
is	NULL
one	NULL
such	NULL
adaptor	NULL
protein	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
Gads	NULL
(	NULL
12	NULL
)	NULL
,	NULL
Vav	NULL
(	NULL
28	NULL
,	NULL
29	NULL
,	NULL
37	NULL
)	NULL
,	NULL
SLAP-130	NULL
(	NULL
FYB	NULL
)	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
,	NULL
and	NULL
other	NULL
as	NULL
yet	NULL
unidentified	NULL
molecules	NULL
.	NULL

Although	NULL
these	NULL
protein-protein	NULL
interactions	NULL
have	NULL
been	NULL
documented	NULL
,	NULL
their	NULL
physiological	NULL
importance	NULL
remains	NULL
un-clear	NULL
.	NULL

Because	NULL
SLP-76	NULL
and	NULL
Vav	NULL
function	NULL
synergistically	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
augment	NULL
TCR	NULL
signaling	NULL
leading	NULL
to	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
(	NULL
29	NULL
)	NULL
,	NULL
we	NULL
initiated	NULL
a	NULL
series	NULL
of	NULL
experiments	NULL
to	NULL
map	NULL
the	NULL
tyrosines	NULL
of	NULL
SLP-76	NULL
important	NULL
for	NULL
the	NULL
SLP-76/Vav	NULL
interaction	NULL
and	NULL
to	NULL
ask	NULL
about	NULL
the	NULL
functional	NULL
consequences	NULL
of	NULL
their	NULL
binding	NULL
.	NULL

These	NULL
experiments	NULL
have	NULL
led	NULL
to	NULL
a	NULL
number	NULL
of	NULL
surprising	NULL
findings	NULL
.	NULL

We	NULL
and	NULL
others	NULL
have	NULL
shown	NULL
previously	NULL
that	NULL
the	NULL
association	NULL
between	NULL
SLP-76	NULL
and	NULL
Vav	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
Vav	NULL
SH2	NULL
domain	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
16210	NULL
A	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Overexpression	NULL
of	NULL
SLP-76	NULL
,	NULL
but	NULL
not	NULL
Vav	NULL
,	NULL
cooperates	NULL
with	NULL
ERK2	NULL
to	NULL
augment	NULL
TCR-induced	NULL
AP-1	NULL
activity	NULL
.	NULL

An	NULL
AP-1-6-Gal	NULL
reporter	NULL
construct	NULL
plus	NULL
an	NULL
Rous	NULL
sarcoma	NULL
virus-luciferase	NULL
construct	NULL
were	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
along	NULL
with	NULL
control	NULL
vector	NULL
or	NULL
cDNA	NULL
encoding	NULL
SLP-76	NULL
,	NULL
ERK2	NULL
,	NULL
SLP-76	NULL
plus	NULL
ERK2	NULL
(	NULL
A	NULL
)	NULL
;	NULL
or	NULL
Vav	NULL
,	NULL
ERK2	NULL
,	NULL
Vav	NULL
plus	NULL
ERK2	NULL
(	NULL
B	NULL
)	NULL
.	NULL

24	NULL
h	NULL
later	NULL
,	NULL
cells	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
UN	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
anti-TCR	NULL
mAb	NULL
C305	NULL
(	NULL
TCR	NULL
)	NULL
B	NULL
or	NULL
PMA	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
8	NULL
h.	NULL
Cells	NULL
were	NULL
then	NULL
lysed	NULL
and	NULL
B-Gal	NULL
activity	NULL
was	NULL
measured	NULL
.	NULL

The	NULL
B-Gal	NULL
counts	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
Rous	NULL
sarcoma	NULL
virus-luciferase	NULL
counts	NULL
to	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
to	NULL
verify	NULL
the	NULL
expression	NULL
of	NULL
transfected	NULL
ERK2	NULL
,	NULL
SLP-76	NULL
,	NULL
and	NULL
Vav	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
in	NULL
both	NULL
panels	NULL
A	NULL
and	NULL
B	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experi-	NULL
ments	NULL
.	NULL

J	NULL
,	NULL
UN	NULL
;	NULL
#	NULL
,	NULL
TCR	NULL
;	NULL
M	NULL
,	NULL
PMA	NULL
.	NULL

Relative	NULL
Counts	NULL
25000	NULL
20000	NULL
15000	NULL
-I	NULL
10000	NULL
-I	NULL
Relative	NULL
Counts	NULL
5000	NULL
binding	NULL
to	NULL
tyrosine-phosphorylated	NULL
residues	NULL
within	NULL
the	NULL
SLP-76	NULL
amino	NULL
terminus	NULL
(	NULL
28	NULL
,	NULL
29	NULL
,	NULL
37	NULL
)	NULL
.	NULL

In	NULL
experiments	NULL
presented	NULL
in	NULL
this	NULL
study	NULL
we	NULL
found	NULL
that	NULL
although	NULL
the	NULL
binding	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
single	NULL
Vav	NULL
SH2	NULL
domain	NULL
,	NULL
two	NULL
SLP-76	NULL
tyrosines	NULL
,	NULL
Tyr-113	NULL
and	NULL
Tyr-128	NULL
,	NULL
both	NULL
appear	NULL
essential	NULL
for	NULL
this	NULL
association	NULL
.	NULL

This	NULL
is	NULL
particularly	NULL
surprising	NULL
since	NULL
both	NULL
Tyr-113	NULL
and	NULL
Tyr-128	NULL
are	NULL
found	NULL
in	NULL
identical	NULL
sequence	NULL
motifs	NULL
(	NULL
DYESP	NULL
)	NULL
,	NULL
either	NULL
of	NULL
which	NULL
would	NULL
be	NULL
predicted	NULL
to	NULL
bind	NULL
the	NULL
Vav	NULL
SH2	NULL
.	NULL

Although	NULL
we	NULL
are	NULL
not	NULL
yet	NULL
sure	NULL
why	NULL
both	NULL
SLP-76	NULL
tyrosines	NULL
are	NULL
required	NULL
for	NULL
Vav	NULL
bind-ing	NULL
,	NULL
several	NULL
models	NULL
come	NULL
to	NULL
mind	NULL
.	NULL

One	NULL
possibility	NULL
is	NULL
that	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
SLP-76	NULL
is	NULL
sequential	NULL
,	NULL
and	NULL
that	NULL
phosphorylation	NULL
of	NULL
either	NULL
tyrosine	NULL
113	NULL
or	NULL
128	NULL
is	NULL
required	NULL
for	NULL
induced	NULL
or	NULL
maintained	NULL
phosphorylation	NULL
of	NULL
the	NULL
second	NULL
residue	NULL
.	NULL

Thus	NULL
,	NULL
although	NULL
only	NULL
one	NULL
tyrosine	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
direct	NULL
binding	NULL
to	NULL
Vav	NULL
,	NULL
the	NULL
second	NULL
tyrosine	NULL
is	NULL
required	NULL
for	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
Vav-binding	NULL
tyrosine	NULL
.	NULL

However	NULL
,	NULL
while	NULL
mutation	NULL
of	NULL
both	NULL
tyrosines	NULL
113	NULL
and	NULL
128	NULL
abolishes	NULL
TCR-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
SLP-76	NULL
,	NULL
mutants	NULL
with	NULL
either	NULL
Tyr-113	NULL
or	NULL
Tyr-128	NULL
mutated	NULL
individually	NULL
are	NULL
still	NULL
phosphorylated	NULL
following	NULL
TCR	NULL
or	NULL
pervanadate	NULL
stimulation	NULL
,	NULL
making	NULL
this	NULL
explanation	NULL
unlikely	NULL
.	NULL

A	NULL
second	NULL
possibility	NULL
is	NULL
that	NULL
one	NULL
phosphorylated	NULL
tyrosine	NULL
is	NULL
responsible	NULL
for	NULL
directing	NULL
the	NULL
interaction	NULL
with	NULL
the	NULL
Vav	NULL
SH2	NULL
domain	NULL
,	NULL
while	NULL
the	NULL
second	NULL
tyrosine	NULL
is	NULL
required	NULL
for	NULL
stabilizing	NULL
this	NULL
interaction	NULL
,	NULL
perhaps	NULL
through	NULL
maintaining	NULL
a	NULL
structural	NULL
micro-environment	NULL
or	NULL
via	NULL
an	NULL
interaction	NULL
with	NULL
a	NULL
third	NULL
molecule	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
SLP-76	NULL
was	NULL
recently	NULL
shown	NULL
to	NULL
simultaneously	NULL
bind	NULL
to	NULL
the	NULL
SH2	NULL
domains	NULL
of	NULL
Vav	NULL
and	NULL
the	NULL
adapter	NULL
protein	NULL
,	NULL
Neck	NULL
,	NULL
to	NULL
form	NULL
a	NULL
trimolecular	NULL
complex	NULL
(	NULL
55	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
SLP-76/Nck	NULL
interaction	NULL
is	NULL
important	NULL
for	NULL
stabilizing	NULL
the	NULL
association	NULL
between	NULL
SLP-76	NULL
and	NULL
Vav	NULL
.	NULL

Crystal	NULL
or	NULL
solution	NULL
nuclear	NULL
magnetic	NULL
resonance	NULL
determination	NULL
of	NULL
the	NULL
structures	NULL
of	NULL
SLP-76	NULL
,	NULL
Vav	NULL
,	NULL
and	NULL
Nck	NULL
,	NULL
when	NULL
bound	NULL
together	NULL
,	NULL
will	NULL
be	NULL
necessary	NULL
to	NULL
test	NULL
this	NULL
hypothesis	NULL
.	NULL

On	NULL
the	NULL
surface	NULL
,	NULL
a	NULL
second	NULL
finding	NULL
from	NULL
our	NULL
studies	NULL
,	NULL
that	NULL
the	NULL
synergy	NULL
between	NULL
SLP-76	NULL
and	NULL
Vav	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
require	NULL
their	NULL
association	NULL
,	NULL
seems	NULL
surprising	NULL
.	NULL

One	NULL
potential	NULL
explanation	NULL
SLP-76	NULL
and	NULL
Vav	NULL
Function	NULL
in	NULL
Separate	NULL
Signaling	NULL
Pathways	NULL
25000	NULL
AP-1	NULL
Activity	NULL
g	NULL
un	NULL
TCR	NULL
20000	NULL
PMA	NULL
H	NULL
15000	NULL
10000	NULL
5000	NULL
I	NULL
2	NULL
0	NULL
Vector	NULL
SLP-76	NULL
ERK2	NULL
SLP-76+ERK2	NULL
cJ	NULL
un	NULL
TCR	NULL
|	NULL
Vav	NULL
+	NULL
ERK2	NULL
AP-1	NULL
Activity	NULL
Vector	NULL
Vav	NULL
ERK2	NULL
could	NULL
be	NULL
that	NULL
the	NULL
SLP-76	NULL
tyrosine	NULL
mutants	NULL
dimerize	NULL
with	NULL
en-dogenous	NULL
,	NULL
wild-type	NULL
SLP-76	NULL
and	NULL
thus	NULL
interact	NULL
with	NULL
Vav	NULL
indi-rectly	NULL
.	NULL

However	NULL
,	NULL
multiple	NULL
experimental	NULL
approaches	NULL
in	NULL
our	NULL
laboratory	NULL
have	NULL
failed	NULL
to	NULL
demonstrate	NULL
evidence	NULL
for	NULL
a	NULL
SLP-76/	NULL
SLP-76	NULL
interaction	NULL
,	NULL
``	NULL
making	NULL
this	NULL
explanation	NULL
unlikely	NULL
.	NULL

Moreover	NULL
,	NULL
our	NULL
result	NULL
is	NULL
consistent	NULL
with	NULL
several	NULL
other	NULL
observa-tions	NULL
.	NULL

First	NULL
,	NULL
when	NULL
SLP-76	NULL
mutants	NULL
Y113F	NULL
and	NULL
Y128F	NULL
are	NULL
overexpressed	NULL
at	NULL
high	NULL
levels	NULL
,	NULL
they	NULL
augment	NULL
IL-2-NFAT	NULL
promoter	NULL
activity	NULL
to	NULL
a	NULL
level	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
wild-type	NULL
SLP-76	NULL
(	NULL
11	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
in	NULL
this	NULL
assay	NULL
,	NULL
SLP-76	NULL
can	NULL
function	NULL
independently	NULL
of	NULL
its	NULL
ability	NULL
to	NULL
bind	NULL
Vav	NULL
.	NULL

Second	NULL
,	NULL
SLP-76	NULL
and	NULL
Vav	NULL
syn-ergize	NULL
in	NULL
augmenting	NULL
basal	NULL
IL-2-NFAT	NULL
promoter	NULL
activity	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
although	NULL
under	NULL
these	NULL
conditions	NULL
,	NULL
SLP-76	NULL
is	NULL
not	NULL
phosphorylated	NULL
and	NULL
does	NULL
not	NULL
bind	NULL
Vav	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Third	NULL
,	NULL
it	NULL
was	NULL
reported	NULL
that	NULL
in	NULL
the	NULL
T	NULL
cell	NULL
hybridoma	NULL
DC27.10	NULL
,	NULL
where	NULL
there	NULL
is	NULL
no	NULL
detectable	NULL
association	NULL
between	NULL
SLP-76	NULL
and	NULL
Vav	NULL
(	NULL
even	NULL
following	NULL
TCR	NULL
stimulation	NULL
)	NULL
,	NULL
TCR	NULL
ligation	NULL
still	NULL
induces	NULL
IL-2	NULL
production	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
have	NULL
found	NULL
recently	NULL
that	NULL
mice	NULL
made	NULL
deficient	NULL
in	NULL
SLP-76	NULL
expression	NULL
by	NULL
homologous	NULL
recombination	NULL
have	NULL
a	NULL
much	NULL
more	NULL
profound	NULL
defect	NULL
in	NULL
T	NULL
cell	NULL
development	NULL
than	NULL
do	NULL
mice	NULL
which	NULL
lack	NULL
expression	NULL
of	NULL
Vav	NULL
,	NULL
suggesting	NULL
that	NULL
SLP-76	NULL
and	NULL
Vav	NULL
do	NULL
not	NULL
function	NULL
entirely	NULL
in	NULL
the	NULL
same	NULL
pathway	NULL
(	NULL
19	NULL
,	NULL
20	NULL
,	NULL
30	NULL
,	NULL
31	NULL
,	NULL
56	NULL
)	NULL
.	NULL

Collectively	NULL
,	NULL
these	NULL
observations	NULL
,	NULL
together	NULL
with	NULL
the	NULL
experiments	NULL
presented	NULL
in	NULL
our	NULL
current	NULL
study	NULL
,	NULL
suggest	NULL
that	NULL
the	NULL
Vav/	NULL
SLP-76	NULL
interaction	NULL
is	NULL
not	NULL
essential	NULL
for	NULL
their	NULL
functional	NULL
synergy	NULL
,	NULL
at	NULL
least	NULL
for	NULL
inducing	NULL
IL-2	NULL
gene	NULL
transcription	NULL
.	NULL

This	NULL
conclusion	NULL
led	NULL
us	NULL
to	NULL
ask	NULL
if	NULL
SLP-76	NULL
and	NULL
Vav	NULL
may	NULL
work	NULL
together	NULL
by	NULL
modulating	NULL
different	NULL
signaling	NULL
pathways	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

There	NULL
are	NULL
several	NULL
examples	NULL
of	NULL
how	NULL
different	NULL
pathways	NULL
may	NULL
enhance	NULL
signals	NULL
leading	NULL
to	NULL
IL-2	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

One	NULL
involves	NULL
the	NULL
cooperation	NULL
between	NULL
signals	NULL
initiated	NULL
from	NULL
the	NULL
TCR	NULL
and	NULL
those	NULL
stimulated	NULL
by	NULL
engagement	NULL
of	NULL
CD28	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Another	NULL
is	NULL
the	NULL
interdependence	NULL
of	NULL
signals	NULL
leading	NULL
to	NULL
translocation	NULL
°	NULL
E.	NULL
J.	NULL
Peterson	NULL
and	NULL
G.	NULL
A.	NULL
Koretzky	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
SLP-76	NULL
and	NULL
Vav	NULL
Function	NULL
in	NULL
Separate	NULL
Signaling	NULL
Pathways	NULL
IL-2	NULL
Promoter	NULL
Activity	NULL
J	NULL
>	NULL
C	NULL
un	NULL
TCR+PMA	NULL
m	NULL
co2s-rma	NULL
Percentage	NULL
of	NULL
Maximum	NULL
Vector	NULL
SLP-76	NULL
Vav	NULL
B	NULL
CD28RE	NULL
Activity	NULL
[	NULL
J	NULL
un	NULL
7-	NULL
[	NULL
Fj	NULL
TCR	NULL
CD28+	NULL
6-	NULL
R	NULL
pua	NULL
5-	NULL
[	NULL
<	NULL
0	NULL
6	NULL
44	NULL
3	NULL
k-£	NULL
3	NULL
3	NULL
o	NULL
w.	NULL
2-1	NULL
0	NULL
Vector	NULL
SLP	NULL
Vav	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Vav	NULL
,	NULL
but	NULL
not	NULL
SLP-76	NULL
,	NULL
regulates	NULL
CD28-induced	NULL
IL-2	NULL
transcription	NULL
.	NULL

A	NULL
,	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
full-length	NULL
IL-2	NULL
promoter	NULL
was	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
along	NULL
with	NULL
control	NULL
vector	NULL
,	NULL
SLP-76	NULL
,	NULL
or	NULL
Vav	NULL
.	NULL

24	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
transfected	NULL
cells	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
UN	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
anti-TCR	NULL
mAb	NULL
C305	NULL
plus	NULL
PMA	NULL
(	NULL
TCR	NULL
+	NULL
PMA	NULL
)	NULL
,	NULL
or	NULL
anti-CD28	NULL
mAb	NULL
A9.3	NULL
plus	NULL
PMA	NULL
(	NULL
CD28	NULL
+	NULL
PMA	NULL
)	NULL
,	NULL
or	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
8	NULL
h.	NULL
Cells	NULL
were	NULL
then	NULL
lysed	NULL
and	NULL
luciferase	NULL
activity	NULL
analyzed	NULL
.	NULL

Results	NULL
are	NULL
shown	NULL
as	NULL
the	NULL
percentage	NULL
of	NULL
the	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
response	NULL
(	NULL
maximum	NULL
)	NULL
for	NULL
each	NULL
group	NULL
.	NULL

Expression	NULL
of	NULL
transfected	NULL
SLP-76	NULL
and	NULL
Vav	NULL
was	NULL
documented	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

B	NULL
,	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
driven	NULL
by	NULL
CD28RE/AP-1	NULL
was	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
along	NULL
with	NULL
control	NULL
vector	NULL
,	NULL
SLP-76	NULL
,	NULL
or	NULL
Vav	NULL
.	NULL

24	NULL
h	NULL
later	NULL
,	NULL
transfected	NULL
cells	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
UN	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
anti-TCR	NULL
mAb	NULL
C305	NULL
(	NULL
TCR	NULL
)	NULL
,	NULL
or	NULL
anti-CD28	NULL
mAb	NULL
9.8A	NULL
plus	NULL
PMA	NULL
(	NULL
CD28	NULL
+	NULL
PMA	NULL
)	NULL
at	NULL
37°C	NULL
for	NULL
8	NULL
h.	NULL
Cell	NULL
lysates	NULL
were	NULL
prepared	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
.	NULL

Results	NULL
were	NULL
calculated	NULL
as	NULL
extent	NULL
of	NULL
luciferase	NULL
activity	NULL
induced	NULL
by	NULL
TCR	NULL
or	NULL
CD28	NULL
treatment	NULL
compared	NULL
with	NULL
unstimulated	NULL
cells	NULL
(	NULL
``	NULL
Fold	NULL
Induction	NULL
``	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
transfected	NULL
SLP-76	NULL
and	NULL
Vav	NULL
was	NULL
documented	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
results	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

J	NULL
,	NULL
UN	NULL
;	NULL
#	NULL
,	NULL
TCR	NULL
+	NULL
PMA	NULL
(	NULL
A	NULL
)	NULL
or	NULL
TCR	NULL
alone	NULL
(	NULL
B	NULL
)	NULL
;	NULL
M	NULL
,	NULL
CD28	NULL
+	NULL
PMA	NULL
.	NULL

of	NULL
NFAT	NULL
from	NULL
the	NULL
cytoplasm	NULL
to	NULL
the	NULL
nucleus	NULL
with	NULL
other	NULL
signals	NULL
leading	NULL
to	NULL
AP-1	NULL
activation	NULL
resulting	NULL
in	NULL
stimulating	NULL
promoter	NULL
elements	NULL
within	NULL
many	NULL
cytokine	NULL
genes	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Our	NULL
studies	NULL
suggest	NULL
that	NULL
the	NULL
synergy	NULL
between	NULL
SLP-76	NULL
and	NULL
Vav	NULL
may	NULL
reflect	NULL
the	NULL
cooperation	NULL
of	NULL
different	NULL
,	NULL
but	NULL
overlapping	NULL
signals	NULL
initiated	NULL
from	NULL
the	NULL
TCR	NULL
and	NULL
CD28	NULL
as	NULL
Vav	NULL
,	NULL
but	NULL
not	NULL
SLP-76	NULL
impacts	NULL
on	NULL
the	NULL
ability	NULL
of	NULL
CD28	NULL
to	NULL
augment	NULL
IL-2	NULL
gene	NULL
promoter	NULL
activity	NULL
.	NULL

This	NULL
finding	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
observation	NULL
that	NULL
while	NULL
Vav	NULL
is	NULL
one	NULL
of	NULL
the	NULL
major	NULL
substrates	NULL
for	NULL
CD28-induced	NULL
PTKs	NULL
(	NULL
57	NULL
)	NULL
,	NULL
we	NULL
find	NULL
that	NULL
SLP-76	NULL
is	NULL
phosphorylated	NULL
to	NULL
only	NULL
a	NULL
very	NULL
limited	NULL
extent	NULL
,	NULL
if	NULL
at	NULL
all	NULL
following	NULL
CD28	NULL
ligation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
suggest	NULL
also	NULL
that	NULL
SLP-76	NULL
and	NULL
Vav	NULL
function	NULL
in	NULL
different	NULL
TCR-stimulated	NULL
pathways	NULL
as	NULL
SLP-76	NULL
,	NULL
but	NULL
not	NULL
Vav	NULL
couples	NULL
the	NULL
TCR	NULL
with	NULL
AP-1	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
recent	NULL
observation	NULL
that	NULL
activation	NULL
of	NULL
ERK	NULL
following	NULL
TCR	NULL
ligation	NULL
is	NULL
diminished	NULL
markedly	NULL
in	NULL
SLP-76-deficient	NULL
Jurkat	NULL
cells	NULL
(	NULL
18	NULL
)	NULL
while	NULL
stimulation	NULL
of	NULL
this	NULL
second	NULL
messenger	NULL
is	NULL
retained	NULL
in	NULL
Vav-deficient	NULL
T	NULL
cells	NULL
(	NULL
56	NULL
,	NULL
58	NULL
)	NULL
.	NULL

16211	NULL
Further	NULL
insight	NULL
into	NULL
the	NULL
potential	NULL
mechanisms	NULL
by	NULL
which	NULL
SLP-76	NULL
exerts	NULL
its	NULL
effects	NULL
on	NULL
TCR-mediated	NULL
signaling	NULL
have	NULL
come	NULL
from	NULL
studies	NULL
of	NULL
the	NULL
SLP-76	NULL
defective	NULL
Jurkat	NULL
mutant	NULL
.	NULL

In	NULL
this	NULL
cell	NULL
line	NULL
,	NULL
TCR	NULL
engagement	NULL
results	NULL
in	NULL
activation	NULL
of	NULL
PTKs	NULL
,	NULL
but	NULL
fails	NULL
to	NULL
couple	NULL
effectively	NULL
with	NULL
the	NULL
phosphatidylinositol	NULL
as	NULL
well	NULL
as	NULL
Ras	NULL
signaling	NULL
pathways	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
SLP-76	NULL
,	NULL
via	NULL
its	NULL
adaptor	NULL
function	NULL
,	NULL
is	NULL
critical	NULL
for	NULL
allowing	NULL
TCR-stimulated	NULL
PTK	NULL
activation	NULL
to	NULL
result	NULL
in	NULL
optimal	NULL
phosphorylation	NULL
of	NULL
phospholipase	NULL
C	NULL
yl	NULL
in	NULL
addition	NULL
to	NULL
signals	NULL
leading	NULL
to	NULL
ERK	NULL
activation	NULL
.	NULL

It	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
,	NULL
however	NULL
,	NULL
exactly	NULL
which	NULL
protein-protein	NULL
interactions	NULL
mediated	NULL
by	NULL
SLP-76	NULL
are	NULL
critical	NULL
for	NULL
these	NULL
more	NULL
downstream	NULL
signals	NULL
to	NULL
occur	NULL
.	NULL

Although	NULL
the	NULL
experiments	NULL
in	NULL
this	NULL
study	NULL
indicate	NULL
that	NULL
for	NULL
TCR-stimulated	NULL
IL-2	NULL
gene	NULL
regulation	NULL
,	NULL
the	NULL
interaction	NULL
between	NULL
SLP-76	NULL
and	NULL
Vav	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
,	NULL
and	NULL
perhaps	NULL
likely	NULL
,	NULL
that	NULL
other	NULL
T	NULL
cell	NULL
activation	NULL
events	NULL
are	NULL
influenced	NULL
by	NULL
SLP-76	NULL
and	NULL
Vav	NULL
and	NULL
require	NULL
their	NULL
interaction	NULL
.	NULL

For	NULL
example	NULL
,	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
the	NULL
interaction	NULL
between	NULL
SLP-76	NULL
and	NULL
Vav	NULL
may	NULL
be	NULL
required	NULL
for	NULL
TCR-induced	NULL
PAK	NULL
activation	NULL
as	NULL
well	NULL
as	NULL
the	NULL
capping	NULL
process	NULL
(	NULL
55	NULL
)	NULL
.	NULL

Since	NULL
several	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
Vav	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
formation	NULL
of	NULL
the	NULL
cap	NULL
following	NULL
TCR	NULL
stimulation	NULL
(	NULL
56	NULL
,	NULL
58	NULL
,	NULL
59	NULL
)	NULL
,	NULL
it	NULL
will	NULL
be	NULL
important	NULL
to	NULL
study	NULL
capping	NULL
function	NULL
in	NULL
SLP-76-deficient	NULL
T	NULL
cells	NULL
.	NULL

We	NULL
are	NULL
currently	NULL
working	NULL
to	NULL
reconstitute	NULL
our	NULL
SLP-76-deficient	NULL
mice	NULL
with	NULL
wild-type	NULL
and	NULL
mutant	NULL
variants	NULL
of	NULL
SLP-76	NULL
to	NULL
begin	NULL
to	NULL
address	NULL
this	NULL
and	NULL
other	NULL
related	NULL
questions	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Drs	NULL
.	NULL

A.	NULL
Weiss	NULL
and	NULL
J.	NULL
Wu	NULL
for	NULL
helpful	NULL
discussions	NULL
and	NULL
Drs	NULL
.	NULL

Jongran	NULL
Lee	NULL
and	NULL
Erik	NULL
Peterson	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Altman	NULL
,	NULL
A.	NULL
,	NULL
Mustelin	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Coggeshall	NULL
,	NULL
K.	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Crit	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

10	NULL
,	NULL
347-391	NULL
2	NULL
.	NULL

Izquierdo	NULL
Pastor	NULL
,	NULL
M.	NULL
,	NULL
Reif	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Cantrell	NULL
,	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
16	NULL
,	NULL
159-164	NULL
.	NULL

Robey	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Allison	NULL
,	NULL
J.	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
16	NULL
,	NULL
306-310	NULL
.	NULL

Kabelitz	NULL
,	NULL
D.	NULL
,	NULL
Pohl	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Pechhold	NULL
,	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
Curr	NULL
.	NULL

Top	NULL
.	NULL

Microbiol	NULL
.	NULL

Immunol	NULL
.	NULL

200	NULL
,	NULL
1-14	NULL
.	NULL

von	NULL
Boehmer	NULL
,	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
Clin	NULL
.	NULL

Immunol	NULL
.	NULL

Immunopathol	NULL
.	NULL

76	NULL
,	NULL
8145-150	NULL
.	NULL

Weiss	NULL
,	NULL
A.	NULL
,	NULL
Chan	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Iwashima	NULL
,	NULL
M.	NULL
,	NULL
Straus	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Irving	NULL
,	NULL
B	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Symp	NULL
.	NULL

Quant	NULL
.	NULL

Biol	NULL
.	NULL

57	NULL
,	NULL
107-116	NULL
7	NULL
.	NULL

Chan	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Iwashima	NULL
,	NULL
M.	NULL
,	NULL
Turck	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
71	NULL
,	NULL
649-662	NULL
8	NULL
.	NULL

Iwashima	NULL
,	NULL
M.	NULL
,	NULL
Irving	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
van	NULL
Oers	NULL
,	NULL
N.	NULL
S.	NULL
,	NULL
Chan	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Science	NULL
263	NULL
,	NULL
1136-1139	NULL
9	NULL
.	NULL

Motto	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Ross	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Wu	NULL
,	NULL
J.	NULL
,	NULL
Hendricks-Taylor	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
and	NULL
Koretzky	NULL
,	NULL
G.	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

1838	NULL
,	NULL
1987-1943	NULL
10	NULL
.	NULL

Wu	NULL
,	NULL
J.	NULL
,	NULL
Katzav	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
4837-4346	NULL
11	NULL
.	NULL

Fang	NULL
,	NULL
N.	NULL
,	NULL
Motto	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Ross	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
and	NULL
Koretzky	NULL
,	NULL
G.	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

157	NULL
,	NULL
3769-3773	NULL
12	NULL
.	NULL

Liu	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
Fang	NULL
,	NULL
N.	NULL
,	NULL
Koretzky	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
and	NULL
McGlade	NULL
,	NULL
J.	NULL
C.	NULL
(	NULL
1999	NULL
)	NULL
Curr	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
67-75	NULL
13	NULL
.	NULL

Jackman	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Motto	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Sun	NULL
,	NULL
Q.	NULL
,	NULL
Tanemoto	NULL
,	NULL
M.	NULL
,	NULL
Turck	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
Peltz	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
Koretzky	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
and	NULL
Findell	NULL
,	NULL
P.	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
7029-7082	NULL
14	NULL
.	NULL

Musci	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Hendricks-Taylor	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
Motto	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Paskind	NULL
,	NULL
M.	NULL
,	NULL
Kamens	NULL
,	NULL
J.	NULL
,	NULL
Turck	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
and	NULL
Koretzky	NULL
,	NULL
G.	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
11674-11677	NULL
15.	NULL
da	NULL
Silva	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Li	NULL
,	NULL
Z.	NULL
,	NULL
de	NULL
Vera	NULL
,	NULL
C.	NULL
,	NULL
Canto	NULL
,	NULL
E.	NULL
,	NULL
Findell	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Rudd	NULL
,	NULL
C.	NULL
E.	NULL
(	NULL
1997	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

94	NULL
,	NULL
7498-7498	NULL
16	NULL
.	NULL

Wardenburg	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
Fu	NULL
,	NULL
C.	NULL
,	NULL
Jackman	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Flotow	NULL
,	NULL
H.	NULL
,	NULL
Wilkinson	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Williams	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
Johnson	NULL
,	NULL
R.	NULL
,	NULL
Kong	NULL
,	NULL
G.	NULL
,	NULL
Chan	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
and	NULL
Findell	NULL
,	NULL
P.	NULL
R.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
19641-19644	NULL
17	NULL
.	NULL

Musci	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Motto	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Ross	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Fang	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Koretzky	NULL
,	NULL
G.	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

159	NULL
,	NULL
1639-1647	NULL
18	NULL
.	NULL

Yablonski	NULL
,	NULL
D.	NULL
,	NULL
Kuhne	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Kadlecek	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Science	NULL
281	NULL
,	NULL
418-416	NULL
19	NULL
.	NULL

Clements	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Yang	NULL
,	NULL
B.	NULL
,	NULL
Ross-Barta	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Eliason	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Hrstka	NULL
,	NULL
R.	NULL
F.	NULL
,	NULL
Williamson	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Koretzky	NULL
,	NULL
G.	NULL
A	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Science	NULL
281	NULL
,	NULL
416-419	NULL
20	NULL
.	NULL

Pivniouk	NULL
,	NULL
V.	NULL
,	NULL
Tsitsikov	NULL
,	NULL
E.	NULL
,	NULL
Swinton	NULL
,	NULL
P.	NULL
,	NULL
Rathbun	NULL
,	NULL
G.	NULL
,	NULL
Alt	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
and	NULL
Geha	NULL
,	NULL
R.	NULL
9	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Cell	NULL
94	NULL
,	NULL
229-238	NULL
21	NULL
.	NULL

Crespo	NULL
,	NULL
P.	NULL
,	NULL
Schuebel	NULL
,	NULL
K.	NULL
E.	NULL
,	NULL
Ostrom	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Gutkind	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
and	NULL
Bustelo	NULL
,	NULL
X.	NULL
R.	NULL
(	NULL
1997	NULL
)	NULL
Nature	NULL
885	NULL
,	NULL
169-172	NULL
22	NULL
.	NULL

Han	NULL
,	NULL
J.	NULL
,	NULL
Das	NULL
,	NULL
B.	NULL
,	NULL
Wei	NULL
,	NULL
W.	NULL
,	NULL
Van	NULL
Aelst	NULL
,	NULL
L.	NULL
,	NULL
Mosteller	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
Khosravi-Far	NULL
,	NULL
R.	NULL
,	NULL
Westwick	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Der	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
and	NULL
Broek	NULL
,	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17	NULL
,	NULL
1346-1353	NULL
23	NULL
.	NULL

Bustelo	NULL
,	NULL
X.	NULL
R.	NULL
,	NULL
Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Barbacid	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Nature	NULL
356	NULL
,	NULL
68-71	NULL
24	NULL
.	NULL

Boguski	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Bairoch	NULL
,	NULL
A.	NULL
,	NULL
Attwood	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
and	NULL
Michaels	NULL
,	NULL
G.	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
Nature	NULL
358	NULL
,	NULL
113	NULL
25	NULL
.	NULL

Han	NULL
,	NULL
J.	NULL
,	NULL
Luby-Phelps	NULL
,	NULL
K.	NULL
,	NULL
Das	NULL
,	NULL
B.	NULL
,	NULL
Shu	NULL
,	NULL
X.	NULL
,	NULL
Xia	NULL
,	NULL
Y.	NULL
,	NULL
Mosteller	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
Krishna	NULL
,	NULL
U.	NULL
M.	NULL
,	NULL
Falck	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
White	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
Broek	NULL
,	NULL
D.	NULL
(	NULL
1998	NULL
)	NULL
Science	NULL
279	NULL
,	NULL
558-560	NULL
26	NULL
.	NULL

Ramos-Morales	NULL
,	NULL
F.	NULL
,	NULL
Druker	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
and	NULL
Fischer	NULL
,	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
Oncogene	NULL
9	NULL
,	NULL
1917-1928	NULL
~	NULL
to	NULL
g	NULL
O	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
16212	NULL
27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

Katzav	NULL
,	NULL
S.	NULL
,	NULL
Sutherland	NULL
,	NULL
M.	NULL
,	NULL
Packham	NULL
,	NULL
G.	NULL
,	NULL
Yi	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
82579-82585	NULL
Tuosto	NULL
,	NULL
L.	NULL
,	NULL
Michel	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Acuto	NULL
,	NULL
O	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184	NULL
,	NULL
1161-1166	NULL
Wu	NULL
,	NULL
J.	NULL
,	NULL
Motto	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Koretzky	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Immunity	NULL
4	NULL
,	NULL
593-602	NULL
Tarakhovsky	NULL
,	NULL
A.	NULL
,	NULL
Turner	NULL
,	NULL
M.	NULL
,	NULL
Schaal	NULL
,	NULL
S.	NULL
,	NULL
Mee	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Duddy	NULL
,	NULL
L.	NULL
P.	NULL
,	NULL
Rajewsky	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Tybulewicz	NULL
,	NULL
V.	NULL
L.	NULL
(	NULL
1995	NULL
)	NULL
Nature	NULL
374	NULL
,	NULL
467-470	NULL
Zhang	NULL
,	NULL
R.	NULL
,	NULL
Alt	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Davidson	NULL
,	NULL
L.	NULL
,	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
and	NULL
Swat	NULL
,	NULL
W.	NULL
(	NULL
1995	NULL
)	NULL
Nature	NULL
874	NULL
,	NULL
4170-473	NULL
Weiss	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Stobo	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1984	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

160	NULL
,	NULL
1284-1299	NULL
Smith	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
and	NULL
Johnson	NULL
,	NULL
K.	NULL
S.	NULL
(	NULL
1988	NULL
)	NULL
Gene	NULL
(	NULL
Amst	NULL
.	NULL
)	NULL

67	NULL
,	NULL
81-40	NULL
Songyang	NULL
,	NULL
Z.	NULL
,	NULL
Shoelson	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
McGlade	NULL
,	NULL
J.	NULL
,	NULL
Olivier	NULL
,	NULL
P.	NULL
,	NULL
Pawson	NULL
,	NULL
T.	NULL
,	NULL
Bustelo	NULL
,	NULL
X.	NULL
R.	NULL
,	NULL
Barbacid	NULL
,	NULL
M.	NULL
,	NULL
Sabe	NULL
,	NULL
H.	NULL
,	NULL
Hanafusa	NULL
,	NULL
H.	NULL
,	NULL
Yi	NULL
,	NULL
T.	NULL
,	NULL
Ren	NULL
,	NULL
R.	NULL
,	NULL
Baltimore	NULL
,	NULL
D.	NULL
,	NULL
Ratnofsky	NULL
,	NULL
S.	NULL
,	NULL
Feldman	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Cantley	NULL
,	NULL
L.	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
2777-2785	NULL
Wu	NULL
,	NULL
J.	NULL
,	NULL
Zhao	NULL
,	NULL
Q.	NULL
,	NULL
Kurosaki	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185	NULL
,	NULL
1877-1882	NULL
Deckert	NULL
,	NULL
M.	NULL
,	NULL
Tartare-Deckert	NULL
,	NULL
S.	NULL
,	NULL
Couture	NULL
,	NULL
C.	NULL
,	NULL
Mustelin	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Altman	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Immunity	NULL
5	NULL
,	NULL
591-604	NULL
Raab	NULL
,	NULL
M.	NULL
,	NULL
da	NULL
Silva	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Findell	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
and	NULL
Rudd	NULL
,	NULL
C.	NULL
E.	NULL
(	NULL
1997	NULL
)	NULL
Immunity	NULL
6	NULL
,	NULL
155-164	NULL
Rao	NULL
,	NULL
A.	NULL
,	NULL
Luo	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Hogan	NULL
,	NULL
P.	NULL
G.	NULL
(	NULL
1997	NULL
)	NULL
Arnu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

15	NULL
,	NULL
707-747	NULL
Luo	NULL
,	NULL
C.	NULL
,	NULL
Burgeon	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184	NULL
,	NULL
141-147	NULL
Pastor	NULL
,	NULL
M.	NULL
I.	NULL
,	NULL
Woodrow	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Cantrell	NULL
,	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Cancer	NULL
Surv	NULL
.	NULL

22	NULL
,	NULL
75-83	NULL
Genot	NULL
,	NULL
E.	NULL
,	NULL
Cleverley	NULL
,	NULL
S.	NULL
,	NULL
Henning	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Cantrell	NULL
,	NULL
D.	NULL
(	NULL
1996	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

15	NULL
,	NULL
3923-3933	NULL
Whitehurst	NULL
,	NULL
C.	NULL
E.	NULL
,	NULL
Boulton	NULL
,	NULL
T.	NULL
G.	NULL
,	NULL
Cobb	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
and	NULL
Geppert	NULL
,	NULL
T.	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

148	NULL
,	NULL
3230-3237	NULL
Jain	NULL
,	NULL
J.	NULL
,	NULL
Valge-Archer	NULL
,	NULL
V.	NULL
E.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

148	NULL
,	NULL
1240-1250	NULL
44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

SLP-76	NULL
and	NULL
Vav	NULL
Function	NULL
in	NULL
Separate	NULL
Signaling	NULL
Pathways	NULL
Allison	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
and	NULL
Krummel	NULL
,	NULL
M.	NULL
F.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
270	NULL
,	NULL
982-983	NULL
Rudd	NULL
,	NULL
C.	NULL
E.	NULL
(	NULL
1996	NULL
)	NULL
Immunity	NULL
4	NULL
,	NULL
527-534	NULL
Fraser	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
4857-4363	NULL
Fraser	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Irving	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Science	NULL
251	NULL
,	NULL
313-316	NULL
Maggirwar	NULL
,	NULL
S.	NULL
B.	NULL
,	NULL
Harhaj	NULL
,	NULL
E.	NULL
W.	NULL
,	NULL
and	NULL
Sun	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1997	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17	NULL
,	NULL
2605-2614	NULL
Kalli	NULL
,	NULL
K.	NULL
,	NULL
Huntoon	NULL
,	NULL
C.	NULL
,	NULL
Bell	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
McKean	NULL
,	NULL
D.	NULL
J	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
3140-3148	NULL
Shapiro	NULL
,	NULL
V.	NULL
S.	NULL
,	NULL
Truitt	NULL
,	NULL
K.	NULL
E.	NULL
,	NULL
Imboden	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17	NULL
,	NULL
4051-4058	NULL
.	NULL

Peterson	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
Clements	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Fang	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Koretzky	NULL
,	NULL
G.	NULL
A	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

10	NULL
,	NULL
337-344	NULL
.	NULL

Pawson	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Scott	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
Science	NULL
278	NULL
,	NULL
2075-2080	NULL
.	NULL

Cantrell	NULL
,	NULL
D.	NULL
(	NULL
1998	NULL
)	NULL
Trends	NULL
Cell	NULL
Biol	NULL
.	NULL

8	NULL
,	NULL
180-182	NULL
.	NULL

Liu	NULL
,	NULL
Y.	NULL
C.	NULL
,	NULL
and	NULL
Altman	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Cell	NULL
Signalling	NULL
10	NULL
,	NULL
377-385	NULL
.	NULL

Bubeck	NULL
Wardenburg	NULL
,	NULL
J.	NULL
,	NULL
Pappu	NULL
,	NULL
R.	NULL
,	NULL
Bu	NULL
,	NULL
J.	NULL
Y.	NULL
,	NULL
Mayer	NULL
,	NULL
B.	NULL
,	NULL
Chernoff	NULL
,	NULL
J.	NULL
,	NULL
Straus	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Chan	NULL
,	NULL
A.	NULL
C.	NULL
(	NULL
1998	NULL
)	NULL
Immunity	NULL
9	NULL
,	NULL
607-616	NULL
.	NULL

Fischer	NULL
,	NULL
K.	NULL
D.	NULL
,	NULL
Kong	NULL
,	NULL
Y.	NULL
Y.	NULL
,	NULL
Nishina	NULL
,	NULL
H.	NULL
,	NULL
Tedford	NULL
,	NULL
K.	NULL
,	NULL
Marengere	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
Kozieradzki	NULL
,	NULL
L	NULL
,	NULL
Sasaki	NULL
,	NULL
T.	NULL
,	NULL
Starr	NULL
,	NULL
M.	NULL
,	NULL
Chan	NULL
,	NULL
G.	NULL
,	NULL
Gardener	NULL
,	NULL
S.	NULL
,	NULL
Nghiem	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
Bouchard	NULL
,	NULL
D.	NULL
,	NULL
Barbacid	NULL
,	NULL
M.	NULL
,	NULL
Bernstein	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Penninger	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
Curr	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
554-562	NULL
Klasen	NULL
,	NULL
S.	NULL
,	NULL
Pages	NULL
,	NULL
F.	NULL
,	NULL
Peyron	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Cantrell	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
and	NULL
Olive	NULL
,	NULL
D.	NULL
(	NULL
1998	NULL
)	NULL
Int	NULL
.	NULL

Immunol	NULL
.	NULL

10	NULL
,	NULL
481-489	NULL
Holsinger	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Graef	NULL
,	NULL
I	NULL
.	NULL

A.	NULL
,	NULL
Swat	NULL
,	NULL
W.	NULL
,	NULL
Chi	NULL
,	NULL
T.	NULL
,	NULL
Bautista	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Davidson	NULL
,	NULL
L.	NULL
,	NULL
Lewis	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
Alt	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1998	NULL
)	NULL
Curr	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
568-572	NULL
Fischer	NULL
,	NULL
K.	NULL
D.	NULL
,	NULL
Tedford	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Penninger	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
Semin	NULL
.	NULL

Immunol	NULL
.	NULL

10	NULL
,	NULL
317-327	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
SLP-76	NULL
and	NULL
Vav	NULL
Function	NULL
in	NULL
Separate	NULL
,	NULL
but	NULL
Overlapping	NULL
Pathways	NULL
to	NULL
Augment	NULL
Interleukin-2	NULL
Promoter	NULL
Activity	NULL
Nan	NULL
Fang	NULL
and	NULL
Gary	NULL
A.	NULL
Koretzky	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1999	NULL
,	NULL
274:16206-16212.	NULL
doi	NULL
:	NULL
10.1074/jb0.274.23.16206	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/274/23/16206	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
59	NULL
references	NULL
,	NULL
29	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
6206	NULL
.	NULL

full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL

